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ABSTRACT 
Agarwood, produced from the trees of Aquilaria species, has been highly 
valued since ancient times for its commercial uses as well as medicinal 
properties such as antidiabetic, constipation and headache. HOGA Gaharu Tea 
products produced by Gaharu Technologies Sdn Bhd (GTSB) were claimed to 
be able to help reduce blood sugar levels and constipation. However, 
traditional recipes are generally not formulated based on scientific data, while 
beneficial claims are often not substantiated scientifically. Based on recent 
literature reviews, it has been found that the major phytochemicals 
responsible for the reported antidiabetic and laxative effects of Aquilaria 
sinensis are due to mangiferin (1) and genkwanin 5-O-β-primeveroside (4), 
respectively (Hara et al., 2008; Ito et al., 2012). In the present study, both 
mangiferin (1) and genkwanin 5-O-β-primeveroside (4) have been successfully 
isolated from the acetone and MeOH extracts of gaharu leaf material, along 
with naringenin (2) and iriflophenone 2-O-α-rhamnoside (3).  
Through MTT assay, safe concentration ranges (above IC50) were determined 
for all test samples to be subjected to gluconeogenesis assay. Glucose 
concentration values (µM) are normalised by amount of protein (µg) present 
in each well as determined from the Bradford Protein assay. It has been 
shown that mangiferin in various concentrations showed significant glucose 
suppression effect, while genkwanin 5-O-β-primeveroside was practically 
ineffective. Normalised gluconeogenesis assay has shown that leaf water 
extract, with the highest amount of mangiferin (6.00% w/w), exhibited the 
best glucose production-suppression activity (0.00035 M/g) relative to 
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control (0.00254 M/g). This is followed by twig (0.00090 M/g) which 
contain 0.50% w/w of mangiferin. Bark (0.00223 M/g) and young shoot 
(0.00215 M/g) showed no significant glucose suppression activity 
compared to control, which correlated to the fact that mangiferin was 
undetectable in these two plant parts. As for the tea products, both Gaharu 
Tea and Gaharu Cool Tea showed comparable normalised glucose 
concentration values (0.00172 and 0.00183 M/g, respectively), which 
correlated to the comparable amounts of mangiferin detected in Gaharu Tea 
(1.33% w/w) and Gaharu Cool Tea (1.66% w/w). Only 0.18% w/w of 
mangiferin was detected in GOGA Drink Powder, which corresponded well 
with the high normalised glucose concentration (0.00221 M/g) determined. 
Through HPLC quantitative analysis, the amounts of genkwanin 5-O-β-
primeveroside were also determined, i.e., leaf 0.55%, Gaharu Tea 0.15%, and 
Gaharu Cool Tea 0.11%. Genkwanin 5-O-β-primeveroside was undetectable in 
twig, bark, young shoot, and GOGA Drink Powder. However, no significant 
gluconeogenesis assay results are associated with genkwanin 5-O-β-
primeveroside. From the product consumption perspective, each sachet of 
Gaharu Tea and Gaharu Cool Tea has comparable amount of mangiferin per 
serving (approximately 4.10 mg and 5.70 mg, respectively), whereas a bottle 
of GOGA Drink (300 ml/bottle, which is prepared by dissolving GOGA Drink 
Powder in water) has lesser amount of mangiferin per serving (0.36 mg). 
Therefore, it is speculated that consuming Gaharu Tea and Gaharu Cool Tea 
would result in better glucose suppression activity compared to GOGA Drink 
per serving. 
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Chapter One 
Introduction 
1.1 Background 
Diabetes (or diabetes mellitus) is one of the major diseases that contributed 
to the morbidity and mortality rate worldwide. It is a chronic metabolic 
disorder related to insulin deficiency and/or insulin resistance. Treatments for 
diabetes include diet and lifestyle modifications, as well as pharmacological 
agents such as insulin and oral antidiabetic drugs. However, there are lots of 
documented side effects from taking these pharmacological agents. Besides 
that, not every diabetic community can afford to procure these 
pharmacological agents which need to be taken over a long time, if not for a 
whole life. All these conditions have led to the ongoing search for antidiabetic 
agents from natural sources.  
Agarwood, also known as gaharu, is mainly produced by trees of Aquilaria 
species. Since ancient times, agarwood has been highly valued for its uses as 
incenses for religious purposes, perfumes, and also as traditional medicines 
(Feng et al., 2011). Uses of agarwood in traditional medicine recipes have 
claimed to possess an array of therapeutic and health promoting effects, 
where one of them was antidiabetic effect. However, traditional medicine 
recipes are generally not formulated based on scientific data. Chemical 
analyses are required to determine the bioactive phytochemicals that are 
responsible for the claimed bioactivities, and the isolated bioactive 
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phytochemicals need to be subjected to various bioassays to determine the 
activity and effect on a molecular level. 
1.2 Agarwood and Aquilaria species 
Aquilaria is one of the genera under the Thymelaeaceae family. It is native to 
Southeast Asia region such as Laos, Vietnam, Malaysia, Borneo and etc. This 
genus, along with the Gyrinops genus, is best known for producing agarwood, 
which is the resinous heartwood of the Aquilaria tree. Agarwood is also 
known by other names such as gaharu, aloeswood, jinkoh, eaglewood and etc. 
The agarwood is formed in the tree when it is mechanically wounded and 
then infected by a certain dematiaceous fungus known as Phaeoacremonium 
parasitica. In response to that, the immune system of the tree will produce an 
oleoresin rich in volatile organic compounds to retard the fungal growth and 
activates the healing process (Crous et al., 1996). In nature, only 1 out of 10 
Aquilaria trees produces agarwood. In recent decades, wild Aquilaria trees 
have declined to near extinction due to the fact that the tree has to be cut 
open in order to determine the content and quality of the resin, not to 
mention illegal tree cutting happening everywhere. Eight threatened species 
are currently included in the IUCN (International Union for Conservation of 
Nature 2010.3) red list (The World Bank, 2008). In order to satisfy the market 
needs for sustainable agarwood production, great efforts are taken such as 
cultivation of 6000 A. crassna trees in Phu Quoc Island, Vietnam and also 
researches in artificial inoculation technologies (Nakashima et al., 2005). The 
business involving “the wood of gods” is no small trade as the price range can 
3 
 
go from USD100/kg for low grade up to USD100,000/kg for superiorly pure 
grade. Agarwood is highly-priced and valued due to its characteristic fragrance 
and beneficial properties. It has been used as incense for centuries in Hindu 
and Buddhist ceremonies. In the perfume industry, the essential oil of 
agarwood is highly demanded owing to its unique blend of balsamic and 
sandalwood-ambergris smell. Besides that, its medicinal properties are highly 
appreciated and applied into Ayurvedic, Tibetan and Chinese traditional 
medicines for an array of therapeutic effects such as relieve cough, gastric 
problems, high fever as well as being sedative, carminative and cardiotonic 
(Naef, 2011). 
There are around fifteen species of Aquilaria distributed throughout tropical 
Asia, these 15 species are A. apiculata, A. baillonii, A. banaensae, A. 
beccariana, A. brachyantha, A. cumingiana, A. filaria, A. hirta, A. khasiana, A. 
malaccensis, A. microcarpa, A. rostrata, A. sinensis, A. subintegra, and A. 
crassna. Out of these fifteen species of Aquilaria tree, only the agarwood of A. 
sinensis, A. malaccensis (A. agallocha) and A. crassna are exploited 
commercially (Naef, 2011). Up to date, five Aquilaria species have been found 
scattered from lowland forests up to hill forests in Malaysia. These five 
species are A. beccariana, A. hirta, A. malaccensis, A. microcarpa and A. 
rostrata (Lee et al., 2013). Three species originated from Indochina were 
introduced into Malaysia for the purpose of agarwood production. These 
three species are A. crassna, A. sinensis and A. subintegra, which are mostly 
planted in plantation (Forestry Department Peninsular Malaysia, 2015). 
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1.2.1 Aquilaria sinensis 
A. sinensis tree may grow up to 20 m tall. The bark is smooth and greyish-
brown or light grey in colour, while the twig is covered with short fine hairs. 
The leaves are characterised by elliptic or obovate, 2.8 – 6 cm wide and 5 – 9 
cm long with 15 – 20 pairs of vein. Inflorescences are a terminal or 
subterminal umbel with 6 – 9 flowers. The flowers are greenish-yellow. Its 
puberulous pedicels are up to 4 – 10 mm in length. The calyx tube is 3 – 5 mm 
long. The fruit is a green ovoid-shaped capsule, which can measure up to 1.6 – 
2 cm wide and 3 – 4 cm long. The seed is dark brown colour, ovoid and 
covered with short fine hairs. It can measure up to 7 mm wide and 15 mm 
long (Sam and Noordin, 2017). For more detailed illustration of the flower, 
fruit and the stages of fruit development of A. sinensis, please refer 
Appendices 1-3. 
 
Figure 1.1 – A. sinensis. (a) Upper and lower surfaces of the leaf; (b) veins 
structure on the lower surface of the leaf; (c) inflorescences; (d) fruits; (e) 
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calyx tube with big calyx lobes, clutching on the base of the fruit; (f) 
sometimes the calyx lobes are slightly curved upward; (g) fruit of A. crassna, 
which has similar calyx to that of A. sinensis (Forestry Department Peninsular 
Malaysia, 2015). 
 
1.3 Traditional medicinal uses, phytochemicals and bioactivity of Aquilaria 
species 
Agarwood is used not only as incense for religious ceremonies or perfume for 
centuries, but it also has imperative role in traditional medicines across 
different cultural backgrounds from Middle East to Asia. Agarwood extract has 
been used as one of the active ingredients in Thai traditional medicine such as 
“Krisanaglun”, which was used as antidiarrheal, antispasmodic, and 
cardiovascular enhancer for patient that has fainted. The extract was also 
used in other Thai traditional medicines that was used to treat dysentery and 
skin diseases (Kamonwannasit et al., 2013). It was also reported that the resin 
of agarwood was traditionally used in India to treat gout, paralysis, snakebite, 
and vomiting. (Borris et al., 1988). A. sinensis was part of the mixtures of a 
traditional Chinese herbal cataplasm, Xiaozhang Tie used to treat cirrhotic 
ascites (Xing et al., 2012). Besides that, it was also applied in traditional 
medicine used to treat bruises and fractures (Zhou et al., 2008). In an ethno-
medicinal study conducted in Bangladesh, A. malaccensis was found to have 
been traditionally used by the Manipuri tribal community to treat rheumatism 
(Rana et al., 2010). A review article by Adam et al. (2018) presented that the 
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leaves of A. crassna were used to treat constipation, diabetes, headache, and 
high blood pressure.  
In recent decades, a lot of research has been done on the scientific nature of 
traditional agarwood application as well as developing new products that 
have pharmacological activity from agarwood. Up to date, more than 300 
phytochemicals have been isolated and identified from numerous species 
from the Aquilaria genus. In some review articles, Chen et al. (2012) have 
presented 132 phytochemicals, whereas in Wang et al. (2018) another 154 
new phytochemicals were presented since 2010. Most of the isolated 
phytochemicals can be categorised into 2-(2-phenyl)-4H-chromen-4-one 
derivatives, aromatics, flavonoids, terpenoids, triterpenes, sesquiterpenes, etc. 
Aquimavitalin, a new phorbol ester isolated from the ethanolic extract of A. 
malaccensis, was reported to possess potential antiallergic activity (Korinek et 
al., 2016). Aqueous extracts of fermented green tea with Aquilariae lignum (A. 
malaccensis), which contain phytochemicals such as benzylacetone, p-
methoxybenzylacetone, hydrocinnamic acid, agarospirol, agarofuran, and 
dihydroagarofuran, have shown antidiabetic effect in high fat-fed mouse (Lee 
et al., 2015). β-Caryophyllene, a sesquiterpene isolated from the essential oil 
of A. crassna, has shown selective anticancer, antioxidant and antimicrobial 
activities (Dahham et al., 2015). Iriflophenone 3-C-β-D-glucoside was reported 
as one of the major active compounds in A. crassna leaf with antidiabetic 
activity (Putalun et al., 2013). Kaempferol 3,4,7-trimethyl ether, isolated from 
the leaf of A. subintegra, has shown to possess AChE inhibitory activity 
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(Bahrani et al., 2014). Specific phytochemicals from A. sinensis as well as their 
bioactivities are discussed in the subsequent section (1.3.1). 
 
1.3.1 Phytochemicals and bioactivity of Aquilaria sinensis 
Four fragrant sesquiterpenes, which are 4-hydroxyl-baimuxinol, 7β-H-9(10)-
ene-11,12-epoxy-8-oxoeremophilane, 7α-H-9(10)-ene-11,12-epoxy-8-
oxoeremophilane, and neopetasane, were isolated from A. sinensis and these 
phytochemicals (except 4-hydroxyl-baimuxinol) have shown potential 
acetylcholinesterase (AChE) inhibitory activity, which is the principal 
pharmacotherapy mechanism of drugs used to treat Alzheimer’s disease (Yang 
et al., 2014). Mangiferin and genkwanin 5-O-β-primeveroside were reported 
to be the major phytochemicals responsible for the laxative effect of the 
ethanolic extract of A. sinensis and A. crassna (Hara et al., 2008; Kakino et al., 
2010; Ito et al., 2012). Four new compounds, which are aquilarisinin, 
aquilarisin, hypolaetin 5-O-β-D-glucuronopyranoside, and aquilarixanthone, 
together with another four known compounds, including mangiferin, 
iriflophenone 2-O-α-L-rhamnopyranoside, iriflophenone 3-C-β-D-glucoside, 
and iriflophenone 3,5-C-β-D-diglucopyranoside were isolated 70% aqueous 
ethanolic extract of A. sinensis leaves. All eight of these compounds were 
reported to exhibit α-glucoside inhibitory activity, of which mangiferin 
showing the most potent activity (Feng et al., 2011). A novel benzophenone 
glucoside (aquilarinoside A) and a new flavonoid (7-β-D-glucoside of 5-O-
methylapigenin), along with eight known compounds, including iriflophenone, 
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mangiferin, 5-O-xylosylglucoside of 7-O-methylapigenin, 5-O-xylosylglucoside 
of 7,4’-di-O-methylapigenin, 5-β-D-glucoside of 7,3’-di-O-methylluteolin, 
luteolin, genkwanin, and hydroxygenkwanin were isolated from the leaves of 
A. sinensis. All these compounds (except 5-O-xylosylglucoside of 7,4’-di-O-
methylapigenin and 5-β-D-glucoside of 7,3’-di-O-methylluteolin) showed anti-
inflammatory activity in the neutrophils respiratory burst assay (Qi et al., 
2009). Pranakhon et al. (2015) have isolated five compounds from the 
methanolic extract of A. sinensis leaves, which include 5-hydroxy-7,4’-
dimethoxyflavone, genkwanin, protocatechuic acid, iriflophenone 3-C-β-
glucoside, and mangiferin. All these compounds were found to lower the 
fasting blood glucose activity through mechanism such as enhancement of 
glucose uptake activity.  
 
1.4 Xanthones 
1.4.1 General  
Mangiferin is the major xanthone-type compound that was isolated from 
Aquilaria species and was found to be a main active constituent for the 
antidiabetic effect of Aquilaria species. Xanthones are secondary metabolites 
that occur commonly in higher plant families, fungi and lichen (Negi et al., 
2013). The molecular formula of a basic xanthone structure is C13H8O2 and its 
structure is closely related to that of flavonoid (Figure 1.2). 
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Figure 1.2 – Basic structures of basic xanthone and flavonoid skeleta. 
Flavonoids are found commonly in nature whereas xanthones are mainly 
occurring in limited number of families such as Clusiaceae, Gentianaceae, 
Guttiferae, Moraceae, Polygalaceae (Negi et al., 2013) and Thymelaeaceae (in 
which Aquilaria species belong). Most xanthones isolated from higher plants 
are mainly associated with the families Clusiaceae (55 species in 12 genera) 
and Gentianaceae (28 species in 8 genera) (Vieira and Kijjoa, 2005). Xanthones 
are sometimes found as mono- or poly-methyl ethers, as parent 
polyhydroxylated compounds, or even as glycosides (Hostettmann and Miura, 
1977). 
 
1.4.2 Classification 
Xanthones isolated from natural sources can be classified into six major 
groups based on their structure. These six major groups are simple 
oxygenated xanthones, xanthone glycosides, prenylated xanthones, 
xanthonolignoids, bisxanthones, and miscellaneous xanthones. Table 1.1 
shows an example for each of the six major groups of xanthones. 
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Table 1.1 – Six major groups of xanthones. 
Group Characteristics Example 
Simple oxygenated 
xanthones 
Hydroxy, 
methoxy, or 
methyl groups 
 
2-hydroxyxanthone 
Xanthone 
glycosides 
C- or O-
glycosides 
 
Mangiferin 
Prenylated 
xanthones 
Prenyl group 
(C5) 
 
Isoemericellin 
Xanthonolignoids Benzyl ether 
moiety 
 
Kielcorin 
Bisxanthones Two xanthone 
moieties 
 
Jacarelhyperol A 
Miscellaneous 
xanthones 
Substituents 
not belonging 
to any of the 
five groups 
 
Xanthofulvin 
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1.4.3 Biological activities of xanthones 
Naturally occurring xanthones have emerged as an important class of organic 
compound due to their outstanding biological and pharmacological activities. 
It has been observed that most plant-based chemotherapeutic agents contain 
xanthones as one of the active constituents. As mentioned above, naturally 
occurring xanthones are rare and only limited to a number of families. 
Xanthones belonging to the family Gentianaceae are best known for their 
bitter taste and are used in some traditional remedies to treat fever and loss 
of appetite (Negi et al., 2013). Bellidifolin (extracted from Swertia japonica) 
and Swerchirin (extracted from Swertia longifolia and Swertia chirayita) are 
reported to have strong hypoglycaemic activity (Bajpai et al., 1991; Basnet et 
al., 1995; Shekarchi et al., 2010). Swertia paniculata, which is widely 
distributed throughout the temperate region above 5000 ft sea level at 
Western Himalayas, is used as bitter tonic in the Indian system medicine to 
treat certain mental disorder such as melancholia (Prakash et al., 1982). 
Extract of Swertia hookeri has been found to possess antimicrobial activity 
and also can be used as mood elevator (Ghosal et al., 1980). 
Swertifrancheside isolated from Swertia franchetiana, along with other 
compounds such as triterpene and protolichesterinic acid isolated from other 
natural sources, were found to be potent inhibitors of the DNA polymerase 
activity of HIV-1 reverse transcriptase. (Pengsuparp et al., 1995). A herbal 
formulation known as Ayush-64 which is used to treat malaria contain the 
extract of Swertia chirata (Neena et al., 2000). An O-glycoside xanthone 
known as norswertianolin which is isolated from Swertia purpurascens, has 
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been reported to cause anticonvulsant activity and central nervous system 
depression in albino rats and mice (Ghosal et al., 1974). Eight out of twenty 
xanthones isolated from Swertia mussotii are reported to have significant 
inhibition on hepatitis B virus DNA replication (Cao et al., 2013). The various 
biological activities shown by mangiferin are discussed in the subsequent 
section (1.4.3.1). 
 
1.4.3.1 Mangiferin and its biological activities 
Mangiferin (2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxyxanthen-9-one) is a 
natural C-glucoside xanthone, which can be found abundantly in various parts 
of mango tree (Mangifera indica, family Anacardiaceae) (Biswas et al., 2015). 
Some other plant sources where mangiferin can be isolated include Aquilaria 
species, Bombax malabaricum, Gentiana lutiae, and Swertia chirata. The 
molecular formula of mangiferin is C19H18O11, and it has a molecular weight of 
422.34 g/mol. The chemical structure of mangiferin is illustrated in Figure 1.3. 
 
Figure 1.3 – Chemical structure of mangiferin. 
Mangiferin has been reported to possess an array of therapeutic effects such 
as antidiabetic, anti-inflammatory, antioxidant and laxative. The most studied 
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and prominent bioactivity associated with mangiferin is antidiabetic activity. 
Mangiferin was reported to have antihyperglycemic effect on streptozotocin-
induced diabetic rats (Li et al., 2010), lowers blood lipids which is beneficial 
for type 2 diabetes and metabolic disorder (Huang et al., 2006), as well as 
modulating multiple targets: protein tyrosine phosphatase 1B (Hu et al., 2007), 
glucose transporter protein 4 (GLUT4) (Miura et al., 2001), and α-glucosidase 
(Feng et al., 2011). These findings supported mangiferin to be a potentially 
useful antidiabetic agent. Mangiferin has also been reported to possess anti-
inflammatory and antioxidant properties, such as regulation of the Bcl-2 and 
Bax pathway (Luo et al., 2015) as well as decreasing oxidative stress damage 
(Kavitha et al., 2013). The laxative effect of mangiferin has been reported to 
be caused by activation of the acetylcholine receptors (Kakino et al., 2010). 
 
1.4.3.2 Antidiabetic mechanism of mangiferin  
Gluconeogenesis is a metabolic pathway where glucose is synthesised from 
pyruvate and other non-carbohydrate precursors such as amino acid, glycerol, 
and lactate (Rang et al., 2003). It is the reverse process of glycolysis where 
glucose is broken down into pyruvate. Figure 1.4 illustrates the carbohydrate 
metabolism pathway for glycolysis and gluconeogenesis. 
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Figure 1.4 – Schematic diagram of the carbohydrate metabolism pathway for 
glycolysis and gluconeogenesis (Raval et al., n.d.). 
5’ Adenosine monophosphate-activated protein kinase (AMPK) is a major 
regulator of metabolic homeostasis and cellular energy sensor (Zhang et al., 
2009). It is a heterotrimeric complex made up of a catalytic (α) and two 
regulatory (β and γ) subunits (Hardie et al., 2006). Phosphorylation of 
threonine (Thr)-172 within the α subunit is the prerequisite for AMPK 
activation. Three upstream kinases are known to phosphorylate Thr-172, 
these are: liver kinase B1 (LKB1), calcium-calmodulin-dependent kinase kinase 
β (CaMKKβ) and transforming growth factor (TGF)-β-activated kinase-1 (Tak1) 
(Zhang et al., 2009).  
Mangiferin is known to possess antidiabetic properties. Multiple studies have 
concluded that the antidiabetic property of mangiferin comes from the 
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activation of AMPK (Zhang et al., 2009; Wang et al., 2016). Several versions of 
AMPK activation mechanism by mangiferin were reported. One report 
suggested that mangiferin stimulate AMPK by increasing the AMP/ATP 
(adenosine monophosphate/adenosine triphosphate) ratio (Niu et al., 2012). 
Another study showed that the AMPK stimulation activity of mangiferin could 
be blocked partially by a CaMKKβ inhibitor, suggesting AMPK activation by 
mangiferin may involve the CaMKKβ (Han et al., 2015). 
There are two metabolic pathways that lead to the antidiabetic effect upon 
activation of AMPK by mangiferin. First of all is the increase in basal glucose 
consumption which is AMPK-dependent. Mangiferin has shown to stimulate 
membrane translocation of GLUT4 to the plasma membrane (Girón et al., 
2009). Besides that, mangiferin has also shown to increase glucose and 
pyruvate oxidation as well as ATP production in muscle cells (Apontes et al., 
2014). Both of these mechanisms lead to increased glucose uptake. 
The second metabolic pathway which mangiferin causes antidiabetic effect is 
through gluconeogenesis suppression, which is also AMPK-dependent. There 
are two pivotal enzymes involved in the completion of the gluconeogenesis 
pathway. Phosphoenolpyruvate carboxykinase (PEPCK) is involved in the 
conversion of oxaloacetate into phosphoenolpyruvate at the early stage of 
gluconeogenesis (Méndez-Lucas et al., 2014), whereas as glucose-6-
phosphatase (G6Pase) is responsible for hydrolysing glucose 6-phosphate into 
free glucose and a phosphate group (Ghosh et al., 2002). When transcriptions 
factors such as cAMP-responsive element-binding protein (CREB)-regulated 
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transcription coactivator 2 (CRTC2) and forkhead box O1 (FOXO1) bind to the 
CRE in the genes of PEPCK and G6Pase, expression of these two enzymes is 
induced. However, activation of AMPK suppresses the binding of these two 
transcription factors, leading to the downregulation of PEPCK and G6Pase, 
which translate to the reduction of gluconeogenesis in the liver (Zhang et al., 
2009). Besides that, AMPK activation also increases phosphorylation of 
glycogen synthase kinase 3β (GSK-3β), which reduces the transcriptional 
activity of CRE and gene expression of PEPCK-C in the liver, thus reducing 
gluconeogenesis (Horike et al., 2008). Figure 1.5 shows the overall antidiabetic 
effect of mangiferin upon activation of AMPK. 
 
Figure 1.5 – Schematic diagram of the antidiabetic effect of mangiferin 
through AMPK activation. Increase in AMP/ATP ratio will activate LKB1, 
whereas increase in intracellular calcium will activate CaMKKβ. Activation of 
these upstream kinases will activate AMPK through phosphorylation of Thr-
172 (Zhang et al., 2009).  
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1.5 Flavonoids 
1.5.1 General 
Genkwanin 5-O-β-primeveroside is one of the major flavonoid compounds 
that was isolated from Aquilaria species and was found to be the main active 
constituent for the laxative effect of Aquilaria species (Hara et al., 2008; 
Kakino et al., 2010; Ito et al., 2012). Flavonoids (or bioflavonoids) are 
secondary metabolites of plants and fungi and are the most abundant 
polyphenolic compound found in photosynthesising plant cells and human 
diet (Havsteen, 2002). Flavonoids, come from the Latin word flavus, meaning 
yellow, and are mostly known as plant pigments for producing the many 
colours found in flowers, fruits, and leaves. For example, anthocyanin 
pigments are mainly responsible for the fruit colouration of red-skinned 
grapevines (Castellarin and Di Gaspero, 2007). Besides that, some flavonoids 
such as kaempferol 3-O-β-D-glucopyranosyl (1 → 2)-O-β-D-glucopyranoside 
and kaempferol 3-O-rutinoside isolated from carnation flower cultivar Esperia 
have shown antifungal activity against Fusarium oxysporum, a fungal species 
pathogenic to plants, especially carnation (Galeotti et al., 2008). 
 
1.5.2 Classification 
More than 5000 different flavonoids have been identified and isolated from 
different plant sources. A review by Kristanti et al. (2018) presented a total of 
22 flavonoids previously isolated from A. sinensis. The basic structure of 
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flavonoids is made up of a 15-carbon skeleton comprised of a heterocyclic ring 
and two phenyl rings which are joined up by a linear 3-carbon chain. 
Flavonoids can be divided into six main groups based on the substitution 
patterns of ring C (heterocyclic ring), while the flavonoids within the same 
group can be differentiated by the substitution patterns of ring A and B (the 
two phenyl rings) (Prasain et al., 2010). Figure 1.6 shows the 15-carbon 
skeleton of a flavonoid.  
 
Figure 1.6 – The 15-carbon skeleton of a flavonoid. 
There are six major groups of flavonoids based on the substitution patterns on 
ring C. Table 1.2 summarises the substitution patterns of all these groups, 
with one example from each group given, together with its dietary source. 
Table 1.2 – Six major groups of flavonoids (Hossain et al., 2016). 
Group Structure description Compound Dietary 
source 
Flavonol 
 
3-hydroxy-2-phenyl-
4H-chromen-4-one 
 
Quercetin 
Red 
onion 
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Flavanone 
 
2-phenyl-2,3-dihydro-
4H-chromen-4-one 
 
Naringenin 
Citrus 
Isoflavone 
 
3-phenyl-4H-
chromen-4-one 
 
Genistein 
Soy 
Flavone 
 
2-phenyl-4H-
chromen-4-one 
 
Genkwanin 
Daphne 
genkwa 
Flavan-3-ol 
 
2-phenyl-3,4-dihydro-
2H-chromen-3-ol 
 
Catechin 
Green tea 
Anthocyanin 
 
2-
phenylchromenylium 
(flavylium) 
 
Cyanidin 
Blueberry 
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1.5.3 Biological activities of flavonoids 
Many of the isolated naturally occurring flavonoids have been reported to 
show many health benefits over chemical treatments. For example, quercetin 
was reported to have antioxidant and anti-inflammatory properties (Zhang et 
al., 2011). Several investigations suggested that naringenin supplementation is 
beneficial for obesity, diabetes, hypertension, and metabolic syndrome (Alam 
et al., 2014). A relation between a soy-rich diet and cancer prevention have 
been shown in some epidemiologic studies, which was attributed to the 
presence of genistein in soy-based foods (Spagnuolo et al., 2015). Wang et al. 
(2015) had tested the activity of genkwanin on HT-29 and SW-480 human 
colorectal cancer cell lines in vitro and showed promising antitumor activity. 
Reduction in body fat and malondialdehyde-modified LDL (low-density 
lipoprotein) was reported through daily consumption of tea rich in catechins 
for 3 months (Nagao et al., 2005). Cyanidin, an anthocyanidin which is the 
aglycone form of anthocyanin, was reported to exhibit antioxidant activity on 
the erythrocyte cell membranes of rabbit (Tsuda et al., 1994). The biological 
activities shown by genkwanin 5-O-β-primeveroside are discussed in the 
subsequent section (1.5.3.1). 
 
1.5.3.1 Genkwanin 5-O-β-primeveroside and its biological activities 
Genkwanin 5-O-β-primeveroside is an O-methylated flavone, with a sugar 
moiety known as β-primeveroside attached to the C5 oxygen atom. The 
primeveroside is made up of a β-glucose and a β-xylose. So far it has only 
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been reported to be isolated from Aquilaria species (Ito et al., 2012) and 
Daphne genkwa (Lin et al., 2001). The molecular formula of genkwanin 5-O-β-
primeveroside is C27H30O14, and it has a molecular weight of 578.43 g/mol. 
The chemical structure of genkwanin 5-O-β-primeveroside is illustrated in 
Figure 1.7. 
 
Figure 1.7 – Chemical structure of genkwanin 5-O-β-primeveroside. 
Not many biological activity studies were carried out on genkwanin 5-O-β-
primeveroside. Up to date, only laxative effect (Hara et al., 2008; Kakino et al., 
2010; Ito et al., 2012) and potential antioxidant effect (Supasuteekul et al., 
2017) were reported. A review by Hossain et al. (2016) has shown that all of 
the flavonoids from the six groups (except genkwanin) mentioned above may 
potentially possessed antiobesity and antidiabetic properties. 
 
1.6 Diabetes mellitus 
One of the traditional uses of Aquilaria species is to treat/manage diabetes. 
Diabetes mellitus is a chronic metabolic disorder characterised with 
hyperglycaemia (high blood glucose concentration, fasting blood glucose > 7 
mmol/L, or plasma glucose > 11.1 mmol/L, 2 hours after meal) due to insulin 
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deficiency, insulin resistance or both combined. It is one of the most prevalent 
disease that has high mortality rate if not treated. When there is reduction of 
glucose uptake by skeletal muscles due to reduced glycogen synthesis 
(glycogenesis) and uncontrolled hepatic glucose output (gluconeogenesis), 
hyperglycaemia occurs (Rang et al., 2003). 
 
1.6.1 Classification of diabetes 
There are two types of diabetes mellitus: type 1 diabetes and type 2 diabetes. 
It is estimated that 1 out of 20 of most western countries population suffered 
from diabetes, and 80% of these diabetic patients have type 2 diabetes (Rang 
et al., 2003). In 2017, 3.6 million diabetes cases were reported out of 32 
million Malaysia populations (“Staggering 3.6 mil Malaysians”, 2017).  
 
1.6.1.1 Type 1 diabetes 
Previously known as insulin-dependent diabetes mellitus (IDDM) as the 
patients require insulin injection since their pancreas cannot produce any 
insulin. This is due to complete destruction of the β-cells of the pancreas 
which may have caused by toxin exposure, viral or bacterial infection, or even 
autoimmune response that triggers antibodies to destroy the Langerhans cells 
in genetically predisposed individuals. Most patients do not inherit from their 
parent as the genetic predisposition of type 1 diabetes is moderate. Type 1 
diabetes usually occurs on young individuals and tend to exhibit characteristic 
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symptoms such as increased hunger (polyphagia), thirst (polydipsia) and 
urinary frequency (polyuria) (Boarder et al., 2010). 
1.6.1.2 Type 2 diabetes 
Previously known as non-insulin-dependent diabetes mellitus (NIDDM) since 
insulin injection is not compulsory as insulin is still being produced by the 
pancreas. However, this terminology is no longer valid as majority of the type 
2 diabetes patients still require insulin injection when the oral medication fails. 
Unlike type 1 diabetes, type 2 diabetes has strong genetic predisposition. This 
means that an individual has higher chances of developing type 2 diabetes if 
the disease runs within the family members. Prevalence of type 2 diabetes is 
also influenced by age and ethnicity, with higher incidence being reported to 
occur on older and non-Caucasians individuals. Due to a combination of 
impaired functions of their Langerhans cells such as decreased insulin 
secretion and sensitivity, coupled with increased glucose production in liver, 
type 2 diabetes patients are often obese (Boarder et al., 2010).   
 
1.6.2 Complications of diabetes  
When diabetes is not properly treated, several complications could arise that 
could increase the morbidity and mortality rate of patients. The two most 
common complications are acute complications and long-term complications.  
Acute complications are often metabolic emergencies that could be lethal if 
not treated and occur more commonly for type 1 diabetes patients. The major 
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disease in this category is diabetic ketoacidosis (DKA), which is a metabolic 
emergency with high mortality rate. When insulin is absent in cells such as 
skeletal muscle and adipose tissue that depend on insulin for glucose uptake, 
the breakdown rate of fat (lipolysis) to acetyl-CoA will increase. In some 
serious cases where oxygen and aerobic carbohydrate metabolism are absent, 
the acetyl-CoA will be converted further into acetoacetate, acetone and β-
hydroxybutyrate. The β-hydroxybutyrate accounts for the acidosis while 
acetone causes the patient’s breath to smell like ketone (Boarder et al., 2010).  
A number of organs and cells can be damaged under long-term 
hyperglycaemia through several mechanisms such as non-enzymatic 
glycosylation of proteins and lipids, activation of protein kinase C, and glucose 
forced through the polyol pathway. All these mechanisms lead to 
complications such as thickening of blood vessel walls, cell injury through 
osmosis, microangiopathy and macrovascular disease (Rang et al., 2003; 
Boarder et al., 2010). 
 
1.6.3 Management of diabetes mellitus 
Diabetes mellitus is fatal if not properly managed and the management of this 
disease often involves diet modifications and pharmacological agents. Diet 
modifications involve eating moderate amounts of proper healthy foods at 
regular mealtimes, whereas pharmacological agents involve the use of insulin 
and oral antidiabetic drugs. Insulin is compulsory for type 1 diabetes patients, 
but only required at later stages for type 2 diabetes patients when their 
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pancreatic insulin stores have completely depleted. For type 2 diabetes 
patients, their primary treatment involves diet modifications and oral 
antidiabetic drugs. Therapy of diabetes is monitored using measures such as 
blood glucose level (BGL) and percentage of glycated haemoglobin (HbA1c). 
Even though there is no absolute target value of the measurements for 
diabetic patients, general consensus now is that the closer the value to 
normal BGL and HbA1c, the better the long-term outcomes. The normal BGL 
and HbA1c values are < 6 mmol/L and < 7%, respectively (Boarder et al., 2010). 
 
1.6.3.1 Insulin 
Insulin is a protein composed of 51 amino acids and contain two amino acid 
chains called A chain and B chain. A chain contains 21 amino acids whereas B 
chain contains 30 amino acids, and both chains are linked together by 
disulphide bridges. Insulin is synthesised as a precursor (preproinsulin) in the 
rough endoplasmic reticulum of the β-cells in pancreas. The preproinsulin is 
transported to the Golgi apparatus where it undergoes proteolytic cleavage 
into proinsulin, then to insulin and a fragment of C-peptide molecules with 
unknown function. Insulin and C-peptide are stored in the granules of β-cells 
in equimolar concentrations, ready for cosecretion by exocytosis together 
with small amount of proinsulin. When glucose enters the β-cells through a 
glucose transporter 2 (GLUT2) membrane transporter, it is metabolised into 
pyruvate which in turn increases the production of ATP. The increase in 
intracellular ATP causes a closure of ATP-sensitive potassium channels, which 
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causes a reduction in potassium influx. This leads to depolarisation of the β-
cells membrane and opening of the voltage-dependent calcium channels, 
leading to calcium influx. This signals the translocation and exocytosis of the 
secretory granules of insulin to the β-cell surface, but only in the presence of 
other amplifying messengers such as diacylglycerol (DAG) and non-esterified 
arachidonic acid (Rang et al., 2003; Boarder et al., 2010). 
Even though insulin is a life-saving medication, it is not without some adverse 
effects. Repeated injections at the same spot could cause lipodystrophy 
(abnormal changes in fat distribution) and scarring. Besides looking unsightly, 
this could affect the absorption efficacy of insulin. Therefore, patients are 
advised to rotate the injection sites. Another potentially more life-threatening 
side effect is hypoglycaemia, which could occur from over injection of insulin 
or sudden changes in eating pattern. In severe cases where the patient 
become unconscious, intravenous glucose injection or parenteral therapy with 
glucagon is required (Boarder et al., 2010). 
 
1.6.3.2 Oral antidiabetic drugs 
Oral antidiabetic drugs are only used for management of type 2 diabetes. 
Several classes of oral antidiabetic drugs are now available in the market, 
these include α-glucosidase inhibitors (acarbose), insulin sensitisers 
(metformin), dipeptidyl peptidase 4 inhibitors (sitagliptin), insulin 
secretagogues (glibenclamide), and peroxisome proliferator activated 
receptor gamma (PPARγ) agonists (thiazolidinediones). Each of these drugs 
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produces hypoglycaemic effect through different mechanism of actions 
(Boarder et al., 2010). Even though these drugs are effective against diabetes, 
most of the drugs come with side effects. For example, the daily dose of 
acarbose need to be taken in a gradually increasing manner to avoid 
gastrointestinal complications such as bloating and flatulence due to 
unabsorbed sugars serving as substrates for gastrointestinal bacteria (Boarder 
et al., 2010). Phenformin was one the biguanides under the insulin sensitisers 
category. However, it was withdrawn due to cases of fatal lactic acidosis. 
Metformin is currently the only one drug that remained in use under this 
category of oral antidiabetic drugs, with extremely low prevalence of causing 
lactic acidosis (0.03 cases in 1000 patients per year) as reported in literature 
(Bösenberg and Zyl, 2008). The most common adverse effect of glibenclamide 
is hypoglycaemia and weight gain. Given that most type 2 diabetes patients 
are overweight, sulphonylureas are not the first choice of drugs. 
 
1.6.3.3 Traditional herbal medicines as antidiabetic remedies  
Due to the multiple side-effects that come together with synthetic 
antidiabetic drugs, there is increasing demand by patients on the use of 
natural products with antidiabetic activity.  There have been a number of 
traditional herbal medicines that are used to treat diabetes mellitus since 
ancient time. These traditional herbal medicines can be categorised into four 
categories based on their mechanism of action: 
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(a) Medicines acting like insulin 
Polypeptide-P was isolated from the seeds and other tissues of the fruit of 
Momordica charantia (bitter melon) which was reported to possess 
hypoglycaemic effect when administered subcutaneously to humans and 
langurs (Joseph and Jini, 2013). 
 
(b) Medicines acting on insulin-secreting β-cells 
Aqueous extract of Allium cepa (onion) was found to exhibit promising 
hypoglycaemic and hypolipidaemic effects in alloxan-induced diabetic rats 
by stimulating the release of insulin (Ozougwu, 2011). 
 
(c) Medicines that modify glucose utilisation 
Cyamopsis tetragonolobus (Gowar plant) was reported to exhibit 
hypoglycaemic activity through modification of glucose utilisation by 
increasing the viscosity of the gastrointestinal contents and slowing the 
gastric emptying (Wadkar et al., 2008).  
 
(d) Miscellaneous mechanisms 
Attele et al. (2002) have found that Panax Ginseng berry extract 
significantly improved glucose homeostasis and systemic insulin sensitivity 
in obese mice. Curcuma longa (turmeric) extracts were found to exhibit 
potent inhibitory activity on α-glucosidase activities and glycation 
reactions (Lekshmi et al., 2014). 
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1.7 Gaharu Technologies Sdn Bhd (GTSB) 
GTSB undertakes intensive cultivation of gaharu-producing Aquilaria plants on 
a commercial scale at Gaharu Tea Valley Gopeng. GTSB has become successful 
in large-scale gaharu plantation and its management with full support from its 
subsidiary, Envirotech Management Sdn Bhd. GTSB also has an R&D 
laboratory to perform tests on Aquilaria plants for the purpose of enhancing 
the quality of the agarwood and the commercial products derived from the 
Aquilaria trees. Specifically, GTSB has an array of tea products (mixture of 
different plant parts from the cultivated Aquilaria trees) marketed under the 
brand name HOGA. Selected tea products include HOGA Gaharu Tea, HOGA 
Fruit Tea, and GOGA Drink, of which the former is one of the first local 
agarwood tea products marketed locally (Figure 1.8). HOGA Gaharu Tea and 
HOGA Fruit Tea come in tea bags, while GOGA Drink is sold as bottled drinks. 
For the present study, Gaharu Tea, Gaharu Cool Tea (raw material of HOGA 
Fruit Tea) and GOGA Drink Powder (to be made into GOGA Drink) were used 
for analyses. 
 
Figure 1.8 – HOGA Gaharu Tea, HOGA Fruit Tea, and GOGA Drink that are 
being sold in the market (Gaharu Tea Valley Gopeng, n.d.). 
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A lot of health beneficial claims are associated with the HOGA Gaharu Tea 
products, which are illustrated in Figure 1.9. 
 
Figure 1.9 – Screenshot of the GTSB homepage about the health beneficial 
claims of the HOGA Gaharu Tea Products (Gaharu Tea Valley Gopeng, n.d.).  
Recent research activities on the leaves of A. sinensis and A. crassna have 
revealed that mangiferin and genkwanin 5-O-β-primeveroside played major 
roles for their associated biological activities, which are anti-diabetic and 
laxative, respectively (Hara et al., 2008; Kakino et al., 2010; Ito et al., 2012). In 
order to increase the commercial value of the tea products, which are claimed 
to help in reducing blood sugar levels and constipation, GTSB proposed to 
carry out detailed chemical analyses on the extracts of their raw materials (e.g. 
bark, leaf, twig, and young shoot) and HOGA tea products to determine the 
presence of the two bioactive phytochemicals. These two bioactive 
phytochemicals can also be used as biomarkers in the future to ensure the tea 
products manufactured are maintained at an acceptable standard. 
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1.8 Biological assays 
Three biological assays, namely, MTT assay, gluconeogenesis assay and 
Bradford protein assay, were undertaken in this research project to determine 
the hepatic glucose production-lowering effect of two of the major 
phytochemicals isolated from A. sinensis, the water extracts of the raw 
materials (plant parts), as well as three HOGA Gaharu Tea products.   
 
1.8.1 MTT assay 
MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay is a 
colorimetric assay to determine the cytotoxicity of potential medicinal agent 
and to establish a safe concentration range of treatment to be used on cell in 
experiment. Yousefi et al. (2017) have used MTT assay to assess anticancer 
activity of fucoxanthin-containing extracts on breast cancer cells line and 
normal human skin fibroblast cells line to specify the cytotoxic effects. In this 
research, it was performed to determine a safe concentration range of 
treatments (above IC50, where more than 50% of the cells are still viable) that 
can be used for gluconeogenesis assay. Viable cells are capable of reducing 
the tetrazolium dye MTT to its insoluble formazan through NADPH-dependent 
cellular oxidoreductase enzyme (Berridge et al., 2005). Since reduction of MTT 
is dependent on the cellular metabolic activity of cells, a high absorbance 
reading at 560 – 570 nm indicates high concentration of formazan, which 
translate to high amount of rapidly dividing viable cells which exhibit high 
rates of MTT reduction (Brescia and Banks, 2009).     
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Figure 1.10 – Reduction of yellow tetrazolium dye MTT into purple formazan 
(Bresciaa and Banks, 2009). 
1.8.2 Gluconeogenesis assay 
Gluconeogenesis assay is an easy and sensitive colorimetric assay that is 
commonly used by researchers to determine the amount of glucose produced 
by the cell. Berasi et al. (2006) used the assay to measure the amount of 
glucose produced in an experiment about inhibition of gluconeogenesis 
through transcriptional activation of EGR1 and DUSP4 by AMP-activated 
kinase. It is reflected by the conversion of Amplex Red reagent into resorufin 
(red fluorescence compound) through glucose oxidase and peroxidase 
enzymes activity. In the presence of glucose, glucose oxidase converts the 
glucose molecule into D-gluconolactone and hydrogen peroxide (H2O2). The 
H2O2 then reacts with Amplex Red reagent to form red-fluorescent oxidation 
product, resorufin in the presence of horseradish peroxidase (Debski et al., 
2016). The absorbance intensity at 560 nm is proportional to glucose 
concentration. Figure 1.11 illustrates the mechanism for glucose detection 
using Amplex Red Glucose Assay Kit for the gluconeogenesis assay.  
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Figure 1.11 – Illustration on the conversion of Amplex Red reagent into 
resorufin in gluconeogenesis assay (Thermo Fisher Scientific, n.d.).  
1.8.3 Bradford Protein assay 
In 1976, Marion Mckinley Bradford developed a quick and accurate 
spectroscopic analytical procedure to measure protein concentration in a 
solution, which was known as Bradford protein assay (Bradford, 1976). 
Moridikia et al. (2018) have used this assay to quantify the lyophilised venom 
of Vipera latifii. The assay was also used by Sahin et al. (2018) to quantify the 
allergenic pollen protein content of Cupressus arizonica Greene., Cupressus 
sempervirens L. and Juniperus oxycedrus L. in Turkey. The Coomassie Brilliant 
Blue G-250 is a red-brown solution (cation) in its acidic solution when not 
bound with protein. Once bound with protein, the dye is converted to blue 
solution (anion) which is detected at 595 nm. The dye-protein complex is 
stabilised through non-covalent interactions such as Van der Waals force with 
the protein’s carboxyl group and electrostatic interaction with the protein’s 
amino group. The amount of complex present in a solution is proportional to 
the protein concentration, which can be estimated through absorbance 
reading (Spector, 1978). 
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Bradford protein assay was run in parallel with gluconeogenesis assay and was 
used to determine protein concentration of individual well of the same 24-
well plate used in the gluconeogenesis assay. The calculated protein 
concentration was then used to normalized the result from gluconeogenesis 
assay so as to eliminate variable such as glucose concentration difference due 
to different number of cells in the well. 
 
1.9 Isolation, purification and structure characterization of natural products 
The term “natural products” often refer to secondary metabolites produced 
by an organism that are not absolutely essential for the survival of the 
organism. Since antiquity, natural products have been an important source of 
therapeutic agents and about half of the drugs in the present are derived from 
natural sources. Biodiversity in nature offers a valuable source for novel active 
lead compound discovery. However, a crude natural product extract is a 
complex mixture of compounds where a single separation technique is often 
insufficient to successfully isolate and purify individual compounds. Thus, 
multiple chromatographic techniques such as vacuum column 
chromatography (VCC), thin layer chromatography (TLC), centrifugal TLC 
(CTLC), and high performance liquid chromatography (HPLC), coupled with 
chemical structure characterization techniques such as nuclear magnetic 
resonance (NMR) and mass spectrometry (MS), need to be employed to allow 
isolation, purification and identification of natural products in crude extract 
mixtures. 
35 
 
1.9.1 Vacuum column chromatography (VCC) 
Column chromatography (CC) consists of two phases, namely, a solid 
stationary phase (adsorbent) and a liquid mobile phase. As the mixture of 
compounds move through the stationary phase, they are separated based on 
the interaction between the solutes and the stationary phase. There are two 
types of chromatographic mode, one is adsorption and the other is size 
exclusion.  
In adsorption chromatography, separation is based on the adsorption 
affinities of the compounds and the surface of the stationary phase. The 
extent of adsorption affinity is governed by a number of factors such as van 
der Waal forces, hydrogen bonding, dipole-dipole interactions, and charge 
transfer (Sarker et al., 2006). For size exclusion chromatography, the 
separation is based on a sieving effect, where the stationary phase is made up 
of porous particles. The porous particles provide a continuous decrease in 
accessibility for compounds of increasing size. Therefore, compounds that are 
bigger in size will be eluted first. Generally, sample recovery for this type of 
chromatography is high since the stationary phase is inert (Sarker et al., 2006). 
VCC involves the use of vacuum at the end of a column. It is effective for rapid 
fractionation of crude extracts. The compound fraction eluted together with 
the mobile phase is collected into a Buchner flask and can be concentrated in 
vacuo later. Figure 1.12 shows the setup of VCC. 
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Figure 1.12 – VCC setup (Sarker et al., 2006). 
 
1.9.2 Thin layer chromatography (TLC) 
TLC is one of the oldest, easiest and cheapest forms of chromatography. It 
utilizes the separation of organic compound mixture on a thin layer of 
adsorbent (silica gel) coated on an aluminium or glass sheet. When a mixture 
is loaded as a spot onto the bottom of a TLC plate and placed into a tank with 
a suitable solvent just enough to wet the part below the spot, the solvent 
front will move up the TLC plate through capillary action. As the plate 
develops, compounds of different polarity and affinity to the solvent and 
sorbent will move up different distances, which are quantified in Rf (retention 
factor) values. Rf value is defined as:  
𝑅𝑓 =
Distance of compound from origin (the spot)
Distance of solvent front from origin
 
In the case where the sorbent is silica (polar), a polar compound will have 
higher affinity for the sorbent and thus travels slowly up the plate. This will 
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give a low Rf value for that particular compound. The Rf value can be increased 
by increasing the polarity of the solvent. Figure 1.13 shows a typical TLC setup. 
 
Figure 1.13 – TLC equipment and development process (Sarker et al., 2006). 
 
1.9.3 Centrifugal thin layer chromatography (CTLC) 
CTLC is a type of planar chromatography, which is similar to TLC. It is used to 
separate mixture of compounds through the action of centrifugal force. Figure 
1.14 shows the schematic view of a CTLC setup known as Chromatotron. 
 
Figure 1.14 – Schematic view of a Chromatotron (Lepoivre, 1972). 
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Prior to sample application, the sorbent layer (silica) is saturated with a 
constant flow rate of starting mobile phase solvent and the sample is 
dissolved in solvent and filtered. Once the sample is loaded and the plate 
starts to spin, a centrifugal force is generated. As the mobile phase elutes, 
compounds with higher affinity to the mobile phase will travel faster to the 
edge of the spinning plate and then swirled off together with the mobile 
phase, while components with higher affinity to the sorbent will travel slowly. 
This will create spherical bands of separated components which allow for 
separate collection. As time passes, the polarity of the mobile phase can be 
increased to elute the more polar compounds that are adsorbed to the 
sorbent layer. Similar to TLC, high polarity solvent will cause the sorbent (silica) 
to dissolve, which would compromise the whole separation process (Agrawal 
and Desai, 2015). 
 
1.9.4 High performance liquid chromatography (HPLC) 
HPLC has become a main choice for isolation and purification of natural 
products. To date, there are various types of HPLC column that operates at 
different modes such as normal-phase, reverse-phase, size exclusion, and ion-
exchange (Valko, 2000). One of the deciding factors for choosing the type of 
HPLC column is the polarity of the mixture of compounds. Since MeOH extract 
was involved in the HPLC isolation and purification process in this research 
project, a reverse-phase HPLC column was used. The stationary phase of the 
column is packed with C-18 coated on 5 μm silica gel. C-18 is a non-polar 
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molecule that is covalently bonded (silanization or carbon loading) to the 
stationary phase particle (silica), thus creating a hydrophobic stationary phase. 
As a result, polar molecules will be eluted faster together with the polar 
(aqueous) mobile phase. In order to elute the retained hydrophobic molecules, 
polarity of the mobile phase need to be reduced by increasing the 
concentration of non-polar (organic) solvent. Besides that, additives such as 
buffers, acids, or bases can be added to suppress the ionization of free 
unreacted silanol group in order to reduce peak tailing (Sarker et al., 2006). 
Figure 1.15 shows the schematic diagram of a HPLC system. 
 
Figure 1.15 – Schematic diagram of a HPLC system featuring an automated 
sample collector (Sarker et al., 2006). 
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1.9.5 Nuclear magnetic resonance (NMR) 
NMR is regarded as an indispensable tool to investigate the chemical 
structures of natural products. Besides solving the gross chemical structures, 
NMR can also be used to study conformation, configuration, molecular 
interactions and motions. In the field of natural products, the major nuclei 
(such as 1H, 13C, 15N, 31P, and 17O) have a spin quantum number (I) of ½. 1H is 
the most common nucleus to be investigated in NMR spectroscopy due to its 
high natural abundance. The second common nucleus to be investigated is 13C 
due to its carbonaceous nature as the skeleton of most organic compounds 
(Colegate and Molyneux, 2008). 
When atomic nuclei that possess non-zero spin quantum number (I) are 
immersed in a magnetic field of strength B0, energy in the range of radio 
frequency (v0) can be absorbed due to a spectroscopic transition that occurs 
between the two energy levels of a nuclear magnetic dipole. This relationship 
is defined by the Larmor equation: 
v0 = γB0/2π 
where γ is a constant known as gyromagnetic ratio, which is dependent on the 
type of nucleus (Tringali, 2001). 
The magnetic resonance of a nucleus is closely related to four major 
properties, namely chemical shift, spin-spin coupling, intensity, and the 
nuclear Overhauser effect (NOE). The degree where a nucleus is shielded from 
external applied magnetic field is dependent on the electron density 
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surrounding it. Thus, the frequency at which the nucleus absorbs energy will 
be different in different chemical environments in relative to a reference 
nucleus and this difference is known as chemical shift (δ). It is expressed in 
parts per million (ppm) as described in the following equation (Tringali, 2001): 
𝛿 (𝑝𝑝𝑚) =  
106(𝑣𝑠𝑎𝑚𝑝𝑙𝑒 − 𝑣𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒)
𝑣𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒
 
Tetramethylsilane (TMS) is the most common reference compound used for 
1H and 13C NMR, which is assigned a chemical shift at 0.00 ppm. The functional 
groups of natural products mostly occur in the range of 0 to 12 ppm for 1H 
NMR and 0 to 230 ppm for 13C (Colegate and Molyneux, 2008).  
Due to mutual spin-pairing tendency of two chemically nonequivalent nuclei, 
they can influence each other by intervening the bonding electrons, which 
result in the splitting of signals which will appear as two lines (d, doublet) in 
the NMR spectrum. This frequency difference is known as coupling constant (J) 
which is expressed in hertz (Hz). This spin-spin coupling (also known as scalar 
coupling) only occur when two nuclei are linked within a maximum of three 
bonds away (Tringali, 2001). 
The intensity (integrated area under the peak) of a 1H NMR signal is 
proportional to the number of protons, which is useful in determining the 
structural formula. As for 13C, this is not the case due to reasons such as 
different relaxation times and NOE enhancement (Tringali, 2001).  
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1.9.6 Mass spectrometry (MS) 
MS is used to measure the mass of a sample by plotting the ion signal as a 
function of mass-to-charge ratio. The mass spectrometer typically consists of 
three parts: ionizer, mass analyser, and detector. Sample is ionized in the 
ionizer to produce positively charged ions with different mass-to-charge ratios 
(m/z), which are then accelerated into the mass analyser in the form of an ion 
beam by accelerating the electric field. Ions of different mass-to-charge ratios 
are separated through electric or magnetic field, which are then filtered and 
focused on the detector to obtain a mass spectrum. The x-axis of the mass 
spectrum records the mass (or m/z), while the y-axis corresponds to the ion 
abundance, which is the numbers of individual ions. The peak with the highest 
ion abundance is known as the base peak, which could relate to the molecular 
ion or to any fragment ions (Herbert and Johnstone, 2003). Each sample has 
its own characteristic mass spectrum which can be used as a fingerprint to 
identify a sample, either by comparison with the library of known spectrum or 
through interpretation of the spectrum itself. Figure 1.16 shows the schematic 
diagram for the formation of a simple mass spectrum. 
43 
 
 
Figure 1.16 – Schematic diagram of the formation of an electron ionization 
mass spectrum from a number (p) of molecules (M) interacting with electrons 
(e-). Peak 1 indicates the molecular ions (M+, the ions with greatest mass), 
peaks 2 and 3 (A+ and B+) indicate the fragment ions. Abundance of each peak 
is indicated by q, r or s. Peak 2 is the base peak as it has the highest ion 
abundance (Herbert and Johnstone, 2003). 
MS, which is efficient at identifying individual substance but not so well with a 
mixture, is often used in tandem with liquid chromatography (LC). LC is 
efficient at separating mixture into individual components. The combination 
of LC-MS could provide information which could not be extracted by either 
technique alone.  However, an interface is required to convert the liquid 
flowing from the end of a column into the ion source of a mass spectrometer. 
Examples of such interface include electrospray, particle beam, thermospray, 
and atmospheric pressure ionization (Herbert and Johnstone, 2003). Figure 
1.17 shows the schematic diagram of an LC-MS system. 
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Figure 1.17 – Schematic diagram of an LC-MS (electrospray ionization 
interface) system (Sarker et al., 2006). 
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1.10 Research objectives 
The ultimate aim of the present research is to investigate whether the various 
plant parts and tea products (Gaharu Tea, Gaharu Cool Tea and GOGA Drink 
Powder) produced by GTSB possess glucose lowering activity in human liver 
cells HepG2 and if so, whether the effect is attributable to the presence of 
mangiferin and/or genkwanin 5-O--primeveroside. The specific objectives of 
the present project are to: 
1. Extract and isolate the mangiferin and genkwanin 5-O--primeveroside 
from the leaf material. 
2. Detect and quantify the presence of mangiferin and genkwanin 5-O--
primeveroside in the water extracts of the various plant parts and tea 
products. 
3. Examine the effect of mangiferin, genkwanin 5-O--primeveroside, the 
water extracts of the various plant parts and tea products on glucose 
production activity in human liver cells (HepG2). 
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Chapter Two 
Experimental 
2.1 Plant source and gaharu tea products  
Four ground plant parts of the A. sinensis were provided by GTSB. Those parts 
include the leaf, bark, twig and young shoot. The species was identified by Dr 
Sam Yen Yen and Mr Mohamad Aidil Noordin (Forest Biodiversity Division, 
Forest Research Institute Malaysia - FRIM). Three raw materials of gaharu tea 
products, namely Gaharu Tea, Gaharu Cool Tea and GOGA Drink Powder were 
also provided by GTSB. The Gaharu Tea is a mixture of ground leaf, twig and 
bark at a certain ratio, whereas the Gaharu Cool Tea has the young shoot 
included into the mixture. GOGA Drink Powder, is a modified product where 
the water extracts of plant parts are spray dried onto the maltodextrin filler 
and mogroside V is added as a natural sweetener. 
 
2.2 Materials 
All solvents used throughout this research for extraction, isolation and 
purification were analytical grade whereas HPLC grade solvents were used for 
reverse phase HPLC. Absolute ethanol and acetone were from RCI-Labscan 
(Bangkok, Thailand). Aluminium chloride hexahydrate, methanol, and 
sulphuric acid were from Merck (New Jersey, United States). Acetic acid, 
acetonitrile, chloroform, ethyl acetate, and formic acid were from 
Friendemann Schmidt (Perth, Australia). Purified water was obtained by a 
Milli-Q HX 7000 SD (Merck) water purification system. 
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Human liver cells (HepG2) were purchased from Riken BRC Cell Bank. Bradford 
Protein Assay Kit, BSA, DMEM (no glucose), DMSO, FBS, L-glutamine (200 mM), 
MTT, penicillin-streptomycin solution, RIPA buffer (10x), RPMI 1640, sodium 
DL-lactate, and sodium pyruvate (100 mM) were purchased from Nacalai 
Tesque (Kyoto, Japan). HEPES solution (1 M) was purchased from Merck. PBS, 
DMEM (no phenol red, glucose, and L-glutamine), and Amplex Glucose 
Oxidase Assay Kit were purchased from Bio-diagnostic (Giza, Egypt). 
Reference drugs used for bioactivity tests were metformin (Merck), insulin, 
and dexamethasone (Nacalai Tesque). 
 
2.3 General experimental procedures used for isolation, purification, and 
quantitative analysis  
1H NMR spectra were recorded in CDCl3 with TMS as internal standard on 
Bruker 600 MHz spectrophotometer. Liquid chromatography – mass 
spectrometry (LC-MS) result were obtained from FRIM by using LTQ Orbitrap 
mass spectrometer in negative mode. Purification of genkwanin 5-O-β-
primeveroside using reverse phase HPLC was performed using Waters Liquid 
Chromatograph with a Waters 600 controller and a Waters 2998 tuneable 
absorbance detector. A semi-prep column (10 x 50 mm, Waters X-Bridge, 
United State) packed with C-18 (ODS, Octadecylsilane) coated on 5 μm silica 
gel was used, at 40°C, and fractions were collected with Waters Fraction 
Collector III. The quantitative analysis of mangiferin and genkwanin 5-O-β-
primeveroside content in different gaharu leaf extracts, plant parts and tea 
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products were carried out by FRIM and Permulab Sdn Bhd, respectively. FRIM 
carried out the analysis through means of a HPLC system (Waters 2535 
quaternary gradient module, Waters 2707 Autosampler and Waters 2998 
photodiode array detector), whereas Permulab Sdn Bhd used Agilent 1220 
HPLC with DAD detector. An analytical column (FRIM: Waters X-Bridge C18, 
4.6 x 250 mm, 5 μm; Permulab Sdn Bhd: Zorbax ODS C18, 4.6 x 250 mm, 5 μm) 
was used and for elution of the constituents, two solvents denoted as A and B 
were employed. A was 0.1% aqueous acetic acid and B was acetonitrile. 
 
2.4 Chromatographic techniques 
Besides HPLC, several chromatographic techniques were used on the crude 
extracts to obtain pure compounds. These included column chromatography, 
thin layer chromatography, centrifugal thin layer chromatography. 
 
2.4.1 Column chromatography (CC) 
Vacuum column chromatography (VCC) was used to fractionate the acetone 
(70.27 g) and methanol (129.95 g) extract, respectively, using Merck silica gel 
60 (0.040 – 0.063 mm) at approximately 20:1 silica to sample ratio. Slurry 
method was used to pack the column where measured amount of silica was 
made into slurry and packed into the column under vacuum condition while 
gently tapping the column with a thick rubber tube to ensure no trapped air 
pocket in the column. The column was refilled repeatedly with CHCl3 until 
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sufficient packing and the column was equilibrated. The crude extract was 
dissolved in minimum amount of solvent of least possible polarity (normally 
CHCl3, with or without minimum amount of MeOH). The extract solution was 
then gently pipetted onto the silica bed. The extract was then eluted using 
CHCl3/MeOH at 99:1 ratio (acetone extract) and 9:1 ratio (MeOH extract), 
respectively, while gradually increasing the solvent polarity by increasing the 
proportion of MeOH. The collected eluents were concentrated and monitored 
using TLC.  
 
2.4.2 Thin layer chromatography (TLC) 
TLC was one of the most commonly used techniques for qualitative analysis 
during isolation works. It can be used to check the purity of sample; to 
determine the optimum starting solvent to be used for CC and CTLC; and to 
detect the presence of conjugated compounds that are UV active. Fractions 
collected from CC and CTLC that showed similar TLC profile can be combined 
together. The TLC plate was an aluminium sheet pre-coated with silica gel 60 
F254 with a standard thickness of 0.25 mm (Merck). Before use, it was 
manually cut into a standard size of 2.5 cm x 10 cm. Samples were spotted 
onto the plate using a glass pipette, and the plate was then placed into a 
saturated chromatographic tank which contained different solvent systems 
(CHCl3/MeOH mixture was commonly used). Once the plate was developed, 
where the solvent front was 1 cm away from the end of the plate, it was 
removed from the tank to air-dry for a few minutes. Once dried, it was 
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sprayed with reagents like aluminium chloride (AlCl3) or 10% sulphuric acid 
(heating required). The plate was then examined under a UV lamp using short 
wave (254 nm) and long wave (365 nm). The spots which reacted with the 
AlCl3 (turned turquoise) or 10% sulphuric acid (turned orange after heated) 
under long wave UV indicated the presence of mangiferin. As for genkwanin 
5-O-β-primeveroside, only AlCl3 spray was used. The blue spot under long 
wave UV indicated the presence of genkwanin 5-O-β-primeveroside. Other UV 
active compounds would give different colour. The solvent systems that were 
commonly used were: 
a) Ethyl acetate: formic acid: acetic acid: water (100:11:11:25) 
b) CHCl3: MeOH (1-30%) 
 
2.4.3 Centrifugal thin layer chromatography (CTLC) 
CTLC was a preparative chromatographic technique used for separation of 
multi-component system through the action of centrifugal force. It was 
carried out using an instrument called Chromatotron as well as a 24 cm in 
diameter circular chromatographic plate that need to be prepared before use. 
The edge of the plate was secured with cellophane tape to form a mould. To 
prepare a 1 mm thick plate, 40 g of silica gel (Kieselgel 60 PF256, Merck) was 
added to about 90 mL of cold distilled water, mixed well and poured while 
manually turning the plate to ensure an even setting. Gentle taping was 
applied while pouring to ensure all trapped air bubble was released to prevent 
cracking. The plate was then left to air-dry for at least an hour before being 
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dried in the oven overnight at 55°C. After the plate was dried, it was shaved 
down to 1 mm thickness using the 1 mm blade and stored. Prior to use, the 
plate was activated at 100°C for one hour and left outside to cool down for 
few minutes. Meanwhile, the Chromatotron and all the tubing were cleaned 
with acetone before securing the plate in place. The sample was dissolved in 
minimum amount of suitable solvent and then gently applied on the centre of 
the spinning plate using a glass pipette to form a thin band. As the solvent 
flowed across the plate, thin bands were separated and eluted at different 
time in accordance to the polarity of the solvent system used. Fractions 
collected were dried by rotary evaporation, examined by TLC and combined 
for fractions with similar TLC profile. The solvent systems that were commonly 
used were: 
a) CHCl3: MeOH (1-25%) 
b) Hexane: CHCl3 (20-100%) 
c) Diethyl ether: MeOH (1-25%) 
 
2.5 Spray reagents 
2.5.1 Aluminium chloride (AlCl3) 
AlCl3 was used to detect the presence of flavonoid within a sample and was 
made by dissolving 5 g of aluminium chloride hexahydrate in 500 mL of 
absolute ethanol.  
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2.5.2 10% Sulphuric acid (H2SO4) 
10% H2SO4 was used to detect the presence of xanthonoid such as mangiferin. 
It was made by mixing 10 mL of 100% H2SO4 in 100 mL of purified water. Small 
amount of H2SO4 was added slowly as heat will be developed in contact with 
water. 
 
2.6 Extraction of plant materials 
Ground dried leaves of A. sinensis was provided by GTSB. 1 kg of leaf was 
macerated in 6 L of acetone overnight. The acetone extract was then 
decanted, filtered and concentrated through rotary evaporation. The same 
plant material was subjected to the same process for another four times using 
new and recovered acetone from the rotary evaporation. 70.27 g of crude 
acetone extract was yielded. The same plant material was air-dried inside a 
fume hood for 1 week, and the same overall process was repeated using 
MeOH instead. The yield of crude MeOH extract was 129.95 g. 
 
2.7 Isolation and purification 
The crude acetone extract was suspended in a CHCl3: MeOH (1:1) mixture for 
2 hours. The suspension was passed through a filter paper (Whatman, 25 μm 
pore size). The insoluble precipitate on the filter paper was scrapped using a 
spatula and collected in a 100 mL beaker. The insoluble precipitate was 
recrystallized with MeOH through air-drying in the fume hood to yield 1.022 g 
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of compound 1 (mangiferin). The filtrate was subjected to VCC with CHCl3: 
MeOH solvent system (10:1, linear increase of MeOH gradient). Based on TLC, 
fractions of similar profiles were pooled into several major fractions (13 
fractions, F1-F13). F10 was suspected to contain the compounds of interest 
and thus subjected for further purification by CTLC and yielded 0.021 g of 
compound 2 (naringenin) and 0.030 g of compound 3 (iriflophenone 2-O-α-
rhamnoside).  
The MeOH extract was subjected to VCC with CHCl3: MeOH solvent system 
(5:1, linear increase of MeOH gradient). Similarly, fractions of similar TLC 
profile were pooled into 7 major fractions altogether (F1-F7). F4 was eluted 
during CHCl3: MeOH (3:1) and was subjected to decantation and 
recrystallization and yielded 0.129 g of pale yellow powder. Preliminary NMR 
result showed characteristic genkwanin peaks with some impurity peaks. 
Further purification using HPLC was undertaken to yield 0.018 g of compound 
4 (genkwanin 5-O-β-primeveroside).  
A flow diagram of the overall isolation procedure is shown in Figure 2.1. 
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Figure 2.1 – Isolation of compounds 1-4 from the leaves of A. sinensis. 
 
2.7.1 Purification of genkwanin 5-O-β-primeveroside by reverse phase HPLC 
The pale yellow powder (impure compound 4) was dissolved in MeOH (4.0 mg 
in 2.0 mL each time) and resolved using a reverse phase semi-prep column 
(eluting solvent: H2O/MeOH, 95:5-10:90 from 1-3 min, hold from 3-6 min, 
10:90-40:60 from 6-8 min, and back to 95:5 from 8-10 min; flow rate 1.0 
mL/min; 30 injections, 50 μL each) to yield a fraction (around 2.5 mg) at 
retention time between 6 min 5 s and 6 min 42 s. A total of 260 injections 
were made, which yielded 0.018 g of pure compound 4. 
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2.8 HPLC quantitative analyses of mangiferin and genkwanin 5-O-β-
primeveroside 
About 100 mg of seven test samples (i.e., bark, leaf, twig, young shoot, 
Gaharu Tea, Gaharu Cool Tea, and GOGA Drink Powder) were sent to FRIM 
and Permulab Sdn Bhd for HPLC quantitative analyses of mangiferin and 
genkwanin 5-O-β-primeveroside contents, respectively. A mixture of 
methanol (2 mL) and water (1 mL) was added to each test sample and 
sonicated for 30 minutes. In the HPLC quantitative analysis of mangiferin, two 
samples, i.e., Gaharu Cool Tea and leaf, were further diluted 3 times and 6 
times, respectively, prior to injection to HPLC. The resulting solution was 
filtered prior to analysis. Table 2.1 shows the HPLC conditions used by FRIM 
and Permulab Sdn Bhd. 
 
Table 2.1 – HPLC conditions used for quantitative analyses of mangiferin and 
genkwanin 5-O-β-primeveroside. 
HPLC System 
(Mangiferin) 
Instrumentation: 
Waters 2535 quaternary gradient module 
Waters 2707 Autosampler 
Waters 2998 photodiode array detector 
 
Column: 
WATERS X-Bridge C18, 5 μm (4.6 mm i.d. x 250 mm) 
HPLC System 
(Genkwanin 5-O-
β-primeveroside) 
Instrumentation: 
Agilent 1220 HPLC 
DAD detector 
 
Column: 
Zorbax ODS C18, 5 μm (4.6 mm i.d. x 250 mm) 
56 
 
Parameter Setting 
Mobile Phase 
(Gradient Elution) 
Time (min) 0.1% Aqueous 
acetic acid (%) 
Acetonitrile (%) 
0.00 90.00 10.00 
30.00 50.00 50.00 
40.00 50.00 50.00 
Flow Rate 
(mL/min) 
1.00 
Injection Volume 
(μL) 
10.00 
Column 
Temperature (°C) 
40.00 
UV Spectra (nm) 330 
Percentage of mangiferin/genkwanin 5-O-β-primeveroside content was 
determined using the formula shown below: 
Concentration (%) = (CS x D x 100) / CE  
CS = Concentration of mangiferin from calibration curve (mg/L) 
D = Dilution factor 
CE = Concentration of test sample extract (mg/L) 
 
2.9 Compounds data 
Mangiferin (1): pale yellow powder; LC-Orbitrap-MS m/z: 421.076 [M-H]- 
(calcd. for C19H18O11-H, 421.334); 1H NMR data, Table 3.2.  
Naringenin (2): white powder; LC-Orbitrap-MS m/z: 271.096 [M-H]- (calcd. for 
C15H12O5-H, 271.248); 1H NMR data, Table 3.3. 
Iriflophenone 2-O-α-rhamnoside (3): pale yellow powder; LC-Orbitrap-MS 
m/z: 391.102 [M-H]- (calcd. for C19H20O9-H, 391.352); 1H NMR data, Table 3.4. 
Genkwanin 5-O-β-primeveroside (4): pale yellow powder; 1H NMR data, Table 
3.5. 
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2.10 Cell culture 
2.10.1 Cell lines and cell culture 
HepG2 was subcultured in RPMI 1640 medium with 10% fetal bovine serum 
(FBS), 1% sodium pyruvate and 1% Penicillin-Streptomycin solution. All cells 
were maintained inside an incubator at 37°C and 5% CO2. 
 
2.10.2 Total dissolved solid (TDS) 
10 g of each tea product (i.e., Gaharu Tea, Gaharu Cool Tea and GOGA Drink 
Powder) and plant part (i.e., bark, leaf, young shoot and twig) was brewed in 
150 mL of hot water (100 °C) for 15 minutes. A brownish solution was 
obtained upon filtration and this solution was used as the stock solution for 
further experiments, i.e., MTT and gluconeogenesis assays. 10, 1 and 0.1 mL 
of each stock solution was dried (by rotavap and desiccator) to determine the 
total amount of dissolved solid in each respective sample volume. A TDS 
calibration curve was then plotted to determine the stock concentration as 
well as the concentrations of all diluted stock solutions. Figure 2.2 shows an 
example of the TDS calibration curve of Gaharu Tea. 
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Figure 2.2 – TDS calibration curve of Gaharu Tea. 
 
2.10.3 MTT assay 
HepG2 were seeded in a 96-well plate and incubated (37 °C, 5% CO2) for 1-2 
days. After that, the cells were starved by replacing the media with (200 
µL/well) no-serum media (RPMI 1640 and Penicillin-Streptomycin) and 
incubated for 4 hours. Treatments with different concentration were 
prepared (dilution with no-serum media) within these 4 hours. After 4 hours, 
the media was aspirated off and 200 µL of each treatment was added to the 
respective well. The plate was then incubated for 16 hours. After 16 hours, 50 
mg of MTT was dissolved in 10 mL PBS to give a 5 mg/mL MTT solution. The 
media was aspirated off and 40 µL of MTT solution was added to each well 
along with 160 µL of no-serum media. The plate was wrapped in foil due to its 
light sensitivity nature of MTT and incubated for 4 hours. After incubation, the 
media was aspirated and replaced with 200 µL of DMSO (dimethyl sulfoxide). 
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The absorbance (abs.) was measured at 560 nm using spectrophotometer. 
Each assay was performed three times in triplicate. The cell viability was 
calculated using the formula stated below: 
Cell viability (%) = [(Abs. of treatment – Abs. of blank) x 100 / Abs. of control] 
 
2.10.4 Gluconeogenesis assay 
HepG2 were seeded in a 24-well plate and incubated for 1-2 days. After that, 
the cells were starved by replacing the media with (1 mL/well) no-serum 
media and incubated for 2 hours. Following that, the no-serum media was 
replaced with 1 mL glucose-free media and incubated for 1 hour. Treatments 
with different concentration were prepared (dilution with glucose production 
media) within this 1 hour. Glucose production media was made up of 47.75 
mL DMEM (no phenol red, glucose, and L-glutamine), 1 mL sodium pyruvate, 
0.5 mL L-glutamine, 0.75 mL HEPES and 200 µl sodium DL-lactate. After 1 hour, 
the media was aspirated off and 1 mL of each treatment was added to the 
respective well. The plate was then incubated for 16 hours. After incubation, 
50 µL from each well was pipetted into a new 96-well plate. A set of known 
standard glucose concentrations (0, 12.5, 25, 50 and 100 µM) was prepared in 
separate wells. Amplex Red glucose reagent was prepared according to 
manufacturer’s protocol. After that, 50 µL of Amplex Red glucose reagent was 
added to each of these wells (including standard glucose, control and 
treatments) and incubated for 30 minutes, wrapped in aluminium foil. The 
absorbance was then measured at 560 nm. The glucose concentration for 
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each treatment was determined by interpolating with the calibration curve of 
the standard glucose solutions. Figure 2.3 shows an example of the standard 
glucose calibration curve. Each assay was performed three times in triplicate. 
 
Figure 2.3 – Standard glucose calibration curve. 
 
2.10.5 Bradford protein assay 
To prepare the RIPA (radioimmunoprecipitation assay) Buffer (1X), the 
commercially available RIPA Buffer (10X) and SDS (sodium dodecyl sulfate) 
solutions were thawed at room temperature and then mixed with purified 
water at the ratio of 1:1:8 respectively. To prepare the standard protein 
solutions, the BSA stock (bovine solution albumin, 2 mg/mL) was diluted (with 
water) accordingly as shown in Table 2.2. 
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Table 2.2 – Standard protein solution dilution. The volume prepared are 
enough for triplicate (10 μL/well). 
Tube Standard 
volume (μL) 
Source Diluent (H2O) 
volume (μL) 
added 
Final protein 
concentration 
(μg/mL) 
1 30 BSA stock 0 2000 
2 60 BSA stock 20 1500 
3 30 BSA stock 30 1000 
4 30 Tube 2 30 750 
5 30 Tube 3 30 500 
6 30 Tube 5 30 250 
7 30 Tube 6 30 125 
8 - - 30 0 
 
In order to prepare the sample solution, the cells attached on the well were 
detached and lysed. Medium of the cultured cells was removed and then the 
cells were washed twice with cold PBS (phosphate buffered saline). 100 μL of 
RIPA Buffer (1X) was added into individual well, and stirred slowly for 5 
minutes in a plate shaker. The cells were then scrapped with a cell scraper. 
The lysate and pellet were transferred into individual microcentrifuge tube. 
The well was then washed with another 400 μL of RIPA Buffer (1X) and pooled 
into the respective microcentrifuge tube. The tubes were incubated in ice for 
15 minutes to increase protein yield. The lysate was then transferred into a 
new tube and centrifuged at 10,000 x g for 10 minutes at 4°C. The 
supernatant containing the total protein extracts was then collected into new 
tube. This 500 μL sample solution containing 1% SDS Solution was then 
diluted 5 times with H2O to yield a solution containing only 0.2% SDS Solution. 
10 μL of standard protein solution, sample solution and blank (H2O) was 
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mixed well with 200 μL of the dye per well in a 96-well plate. The plate was 
wrapped in aluminium foil and incubated at room temperature for 10 minutes. 
After that, the plate was measured at 595 nm using a spectrophotometer. As 
shown in Figure 2.4, a sample of standard protein calibration curve was 
plotted to determine the amount of protein in a well based on UV absorbance, 
before determining the total amount of protein by incorporating the dilution 
factor. After the amount of protein (μg/mL) was determined from the 
equation of the standard curve, the value was then multiplied by 5 (dilution 
factor) and 0.5 (amount of protein in 500 μL) to yield total amount of protein 
(μg). 
 
Figure 2.4 – Standard protein calibration curve.  
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2.10.6 Statistical analysis 
All bioassays were done in triplicate and the data was reported as mean ± 
standard error of mean (SEM). Unpaired t-test was used to determine the 
differences between test samples against control in the MTT and 
gluconeogenesis assays. The null hypothesis stated that “no significant 
difference compared to control”. A p-value of <0.05 was considered as 
significant. Statistical analysis was conducted using GraphPad Prism software. 
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Chapter Three 
Results 
3.1 Isolation and identification of compounds 
The dried leaves (1 kg) were extracted repeatedly in solvents such as acetone 
and methanol and eventually yielded 70.27 g acetone extract and 129.95 g 
MeOH extract respectively. Further purification works were taken and four 
pure compounds were obtained, namely, mangiferin (1), naringenin (2), 
iriflophenone 2-O-α-rhamnoside (3) and genkwanin 5-O-β-primeveroside (4). 
The isolation yields for these compounds from the leaves of A. sinensis are 
shown in Table 3.1. 
Table 3.1 – Isolation yields of compounds from the leaves of A. sinensis. 
Compound Yield (g/kg) 
Mangiferin (1) 1.022 
Naringenin (2) 0.021 
Iriflophenone 2-O-α-rhamnoside (3) 0.030 
Genkwanin 5-O-β-primeveroside (4) 0.018 
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3.1.1 Mangiferin (1) 
Mangiferin (1) was obtained as pale yellow powder. LC-Orbitrap-MS (negative 
mode) measurements yielded a pseudo molecular ion peak at m/z 421.076 
(C19H18O11-H+), corresponding to the molecular formula of mangiferin (1), 
C19H18O11. The 1H NMR data is shown in Table 3.2 while the NMR spectrum is 
shown in Figure 3.1. 
Table 3.2 – 1H NMR data of mangiferin (1) compared to those of literature 
(Hara et al., 2008). 
Position Mangiferin (1) Literature 
4 6.38 s 6.36 s 
5 6.87 s 6.85 s 
8 7.39 s 7.37 s 
OH-1 - 13.77 s 
OH-3 - 10.51 s 
OH-6 - 10.58 s 
OH-7 - 9.68 s 
1’ 4.59 d (9.8) 4.58 d (9.8) 
2’ 4.03 t (9.2) 4.03 dd (9.8, 9.0) 
3’ 3.22 ma 3.22 dd (9.0, 7.8) 
4’ 3.14 ma 3.14 dd (8.2, 7.8) 
5’ 3.22 ma 3.22 dd (8.2, 5.6) 
6’ - 3.34 dd (11.2, 5.6) 
6’ 3.68 d (11.2) 3.67 d (11.2) 
a signals partially obscured by the DMSO signal. CDCl3, 600 MHz (1H) 
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Figure 3.1 – 1H NMR spectrum and the structure of compound 1
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HPLC analysis also confirmed the identity of mangiferin (1) when tested 
against standard mangiferin (Figure 3.2). 
 
Figure 3.2 – HPLC profiling of the isolated sample (compound 1). 
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3.1.2 Naringenin (2) 
Naringenin (2) was obtained as white powder. LC-Orbitrap-MS (negative 
mode) measurements yielded a pseudo molecular ion peak at m/z 271.096 
(C15H12O5-H+), corresponding to the molecular formula of naringenin (2), 
C15H12O5. The 1H NMR data is shown in Table 3.3 while the NMR spectrum is 
shown in Figure 3.3. 
Table 3.3 – 1H NMR data of naringenin (2) compared to those of literature 
(Álvarez-Álvarez et al., 2015). 
Position Naringenin (2) Literature 
2 5.44 dd (13.1, 3.0) 5.40 dd (13.1, 3.0) 
3 2.85 dd (17.2, 3.0) 2.70 dd (17.2, 3.0) 
3 3.13 dd (17.2, 13.1) 3.15 dd (17.2, 13.1) 
6 6.09 d (2) 5.95 d (2) 
8 6.07 d (2) 5.94 d (2) 
2’,6’ 7.45 d (8.6) 7.37 d (8.6) 
3’,5’ 7.21 d (8.6) 6.87 d (8.6) 
OH-5 12.02 s 12.15 s 
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Figure 3.3 - 1H NMR spectrum and the structure of compound 2
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3.1.3 Iriflophenone 2-O-α-rhamnoside (3) 
Iriflophenone 2-O-α-rhamnoside (3) was obtained as pale yellow powder. LC-
Orbitrap-MS (negative mode) measurements yielded a pseudo molecular ion 
peak at m/z 391.102 (C19H20O9-H+), corresponding to the molecular formula of 
iriflophenone 2-O-α-rhamnoside (3), C19H20O9. The 1H NMR data is shown in 
Table 3.4 while the NMR spectrum is shown in Figure 3.4. 
Table 3.4 – 1H NMR data of iriflophenone 2-O-α-rhamnoside (3) compared to 
those of literature (Hara et al., 2008). 
Position 
Iriflophenone 2-O-α-
rhamnoside (3) 
Literature 
3 6.14 d (2) 6.30 d (2) 
5 6.04 d (2) 6.07 d (2) 
2’,6’ 7.55 d (8.7) 7.61 d (8.6) 
3’,5’ 6.80 d (8.7) 6.81 d (8.6) 
Rha-H-1 5.11 d (0.8) 5.22 d (0.8) 
Rha-H-2 a 3.41 dd (3.0, 0.8) 
Rha-H-3 3.09 br d (9.1) 3.10 dd (9.6, 3.0) 
Rha-H-4 3.28 mb 3.29 dd (9.6, 3.6) 
Rha-H-5 3.45 mb 3.44 dd (6.2, 3.6) 
Rha-H-6 1.19 d (6.4) 1.19 d (6.4) 
a completely obscured by the DMSO signal; b signals are overlapping. CDCl3, 
600 MHz (1H) 
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Figure 3.4 - 1H NMR spectrum and the structure of compound 3
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3.1.4 Genkwanin 5-O-β-primeveroside (4) 
Genkwanin 5-O-β-primeveroside (4) was obtained as pale yellow powder. The 
1H NMR data is shown in Table 3.5 while the NMR spectrum is shown in Figure 
3.5. 
Table 3.5 – 1H NMR data of genkwanin 5-O-β-primeveroside (4) compared to 
those of literature (Hara et al., 2008). 
Position 
Genkwanin 5-O-β-
primeveroside (4) 
Literature 
Aglycone Moiety - Genkwanin 
3 6.72 s 6.69 s 
6 6.87 d (2.4) 6.85 d (2.4) 
8 7.05 d (2.4) 7.02 d (2.4) 
OMe 3.90 s 3.89 s 
2’,6’ 7.93 d (8.8) 7.91 d (8.8) 
3’,5’ 6.92 d (8.8) 6.91 d (8.8) 
4’-OH 10.33 s 10.31 s 
Sugar Moiety – 5-O-β-primeveroside 
Glc-H-1 4.78 d (7.6) 4.79 d (7.6) 
Glc-H-2 a 3.39 dd (8.8, 7.6) 
Glc-H-3 a 3.34 dd (9.6, 8.8) 
Glc-H-4 3.28 ma 3.28 dd (9.6, 9.2) 
Glc-H-5 3.56 dd (9.2, 5.2) 3.56 dd (9.2, 5.2) 
Glc-H-6 3.67 mb 3.67 dd (10.6, 1.2) 
Glc-H-6 3.97 dd (10.6, 5.2) 3.97 dd (10.6, 5.2) 
Xyl-H-1 4.18 d (7.6) 4.18 d (7.6) 
Xyl-H-2 3.00 mb 3.00 dd (8.1, 7.6) 
Xyl-H-3 3.10 mb 3.10 dd (8.8, 8.7) 
Xyl-H-4 3.23 mb 3.24 dd (8.8, 5.5) 
Xyl-H-5 3.03 mb 3.03 dd (10.8, 5.5) 
Xyl-H-5 3.70 dd (11, 5) 3.69 dd (10.8, 1.5) 
a completely obscured by the DMSO signal; b signals are overlapping. CDCl3, 
600 MHz (1H) 
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Figure 3.5 - 1H NMR spectrum and the structure of compound 4
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Figure 3.6 shows the HPLC chromatogram of genkwanin 5-O-β-primeveroside 
before and after purification, as well as the purity plot. 
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Figure 3.6 – HPLC chromatogram on the purification of genkwanin 5-O-β-
primeveroside. (a) Before purification; (a-1) Purity plot before purification; (b) 
Isolated peak between 6.08 min and 6.70 min; (b-1) Purity plot of the isolated 
peak. When the purity angle is smaller than the purity threshold, the peak is 
considered spectrally homogenous (i.e., pure) (Waters Corporation, 1999). (b-1) 
has smaller purity angle relative to purity threshold compared to that of (a-1), 
which indicates (b-1) is purer than (a-1).  
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3.2 Extraction yields from TDS 
As mentioned in the method part, 10 g of each tea product (Gaharu Tea, Gaharu 
Cool Tea and GOGA Drink Powder) and plant part (bark, leaf, young shoot and 
twig) were brewed in 150 mL of hot water (100 °C) for 15 minutes and filtrated to 
be used as the stock solution for further experiments. In order to determine the 
concentration of the stock solution, 10.0, 1.0 and 0.1 mL of each stock solution 
were dried (by rotavap and desiccator) to determine the total amount of 
dissolved solid in each of the respective sample volume. A TDS calibration curve 
was then plotted (mass, mg against volume, ml) to determine the stock 
concentration as well as the concentrations of all diluted stock solutions. Table 
3.6 shows the TDS of all the water extracts (tea products and plant parts), final 
stock concentrations as well as the % yield of dissolved solid. Batch 1 and 2 were 
used for Attempt 1 and 2 gluconeogenesis assays, respectively. 
Table 3.6 – TDS of two batches of water extracts of various plant parts and tea 
products. 
Sample Batch 
Total mass dissolved 
(mg) 
Stock 
Concentration 
(mg/ml) 
Dissolved solid 
yield (%) 
10 ml 1 ml 
0.1 
ml 
Gaharu 
Tea 
1 
89.5 9.0 0.8 
9.05 
13.71 
90.7 10.3 1.0 
91.0 10.1 0.7 
2 
93.5 9.9 0.5 
9.23 90.9 9.8 1.0 
92.3 9.7 0.8 
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Gaharu 
Cool Tea 
1 
100.9 10.9 1.2 
10.04 
15.26 
99.5 11.3 1.2 
100.5 10.7 1.2 
2 
102.2 11.0 0.7 
10.29 103.3 12.0 1.1 
103.0 10.0 0.9 
GOGA 
Drink 
Powder 
1 
660.8 68.5 7.0 
65.90 
79.88 
656.1 70.3 6.8 
659.4 67.0 7.1 
2 
406.4 39.8 4.2 
40.607 406.4 41.0 4.0 
405.7 38.2 4.0 
Bark 
1 
117.9 13.1 1.2 
11.92 
18.06 
120.4 12.4 1.3 
119.1 12.3 1.3 
2 
122.0 12.4 1.2 
12.16 121.1 12.6 1.5 
121.5 12.7 1.3 
Leaf 
1 
116.2 11.6 1.4 
11.44 
17.12 
112.8 11.1 1.6 
114.3 11.0 1.5 
2 
111.3 10.4 1.3 
11.37 115.9 10.7 1.5 
114.2 9.9 1.2 
Twig 
1 
53.0 5.4 0.7 
5.22 
7.70 
51.1 5.9 1.0 
52.2 5.7 0.8 
2 
49.6 5.4 0.5 
5.03 50.0 5.7 0.8 
51.1 5.6 0.7 
Young 
Shoot 
1 
94.5 10.0 1.2 
9.45 
14.13 
93.7 10.1 1.2 
95.1 9.8 1.3 
2 
96.4 9.6 1.2 
9.38 91.4 10.5 1.2 
93.5 9.8 1.1 
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3.3 HPLC quantitative analyses of mangiferin and genkwanin 5-O-β-
primeveroside 
Water extract samples of the various plant parts and tea products were subjected 
to HPLC quantitative analyses for the amount of mangiferin and genkwanin 5-O-
β-primeveroside present in the individual samples. The results are shown as 
mean ± S.D. (n=3) (Table 3.7).  
Table 3.7 – Quantitative analysis of mangiferin and genkwanin 5-O-β-
primeveroside. The mangiferin content of MeOH extract is highest (9.76 g of 
mangiferin/100 g of extract), followed by leaf (6 g/100 g). Content of genkwanin 
5-O-β-primeveroside is highest in leaf (0.55 g/100 g), followed by Gaharu Tea 
(0.15 g /100g), and the least in Gaharu Cool Tea (0.11 g/100 g). 
Sample Code 
Average amount of 
mangiferin (% w/w) ± 
S.D. 
Average amount of 
genkwanin 5-O-β-
primeveroside (% w/w) 
± S.D. 
Gaharu Tea AQGT 1.33 ± 0.03 0.15 ± 0.00 
Gaharu Cool Tea AQGCT 1.66 ± 0.25 0.11 ± 0.00 
GOGA Drink Powder AQGDP 0.18 ± 0.01 ND 
Twig AQT 0.50 ± 0.02 ND 
Bark AQB ND ND 
Leaf AQL 6.00 ± 0.40 0.55 ± 0.01 
Young Shoot AQYS ND ND 
Acetone Extract AQAE 5.45 ± 0.00 NM 
MeOH Extract AQME 9.76 ± 0.01 NM 
* ND - Not detectable; NM – Not measured. 
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3.4 Biological assays 
3.4.1 MTT assay 
MTT assay was performed to determine a safe concentration range of treatments 
(above IC50) that could be used to conduct the gluconeogenesis assays. Figure 3.7 
shows the average cell viability percentages for all test samples from the MTT 
assays. All samples were evaluated three times, each in triplicate. 
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Figure 3.7 – MTT assays for: (A) Acetone and methanol extracts of leaves, positive 
(insulin and metformin) and negative (dexamethasone) drug controls; (B) Water 
extract of tea products; (C) Water extracts of plant parts; (D) Mangiferin and 
genkwanin 5-O-β-primeveroside. Data are expressed as mean ± SEM (n=3). *; 
p<0.05, **; p<0.01 and ***; p<0.001. 
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Based on Figure 3.7 (A), acetone and MeOH extracts showed significant reduction 
in cell viability relative to control at concentration of 1000 μg/ml (49%, p<0.01 
and 53%, p<0.01 respectively). At 500 μg/ml, both acetone and MeOH extracts 
showed comparable cell viability reduction with cell viability being well above 
50%. Thus, safe concentration ranges for these two extracts were determined to 
be below 500 μg/ml. For insulin, significant cell viability reduction was 
determined at concentration above 1 μΜ (69%, P<0.05), where 10 μΜ (23%, 
p<0.001) and 100 μΜ (0%, p<0.01) killed more than half of the cells. Therefore, 
maximum concentration of insulin to be used for gluconeogenesis was 1 μM. At 
10 mM, although metformin showed significant cell viability reduction (65%, 
p<0.05), cell viability is still above 50%. Thus any concentration below 10 mM was 
considered safe for gluconeogenesis assay. Last but not least, dexamethasone 
showed no significant cell viability reduction from 1 to 50 μM. Therefore, 
concentration within this range was used in gluconeogenesis assay. For 
comparability purpose, the concentration used in gluconeogenesis assay for the 
acetone and MeOH extracts was 100 μg/ml, whereas concentration for the three 
drug controls was set at 1 μM. 
From Figure 3.7 (B), Gaharu Tea and Gaharu Cool Tea showed significant 
reduction in cell viability relative to control at 10,000 μg/ml (3%, p<0.01 and 0.1%, 
p<0.01, respectively). At 1000 μg/ml, both Gaharu Tea and Gaharu Cool Tea 
showed comparable cell viability reduction but not significant. Thus, safe 
concentration range for these two extracts was determined as below 1000 μg/ml 
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(maximum). As for GOGA Drink Powder, concentrations at 10,000 and 1000 
μg/ml showed significant cell viability reduction (0.6%, p<0.01 and 52%, p<0.05 
respectively). Thus, safe working concentration range was determined at 100 
μg/ml or below. For comparability purpose, the concentration used in 
gluconeogenesis assay for these three tea products was 10 μg/ml. 
From Figure 3.7 (C), bark showed significant reduction in cell viability relative to 
control at 10,000 and 1000 μg/ml (8%, p<0.01 and 45%, p<0.05, respectively). 
Twig also showed significant cell viability reduction at 10,000 μg/ml (5%, p<0.01). 
As for leaf and young shoot, significant reduction in cell viability was only 
observed at 10,000 μg/ml (22%, p<0.05 and 42%, p<0.05, respectively). For 
comparability purpose, the concentration used in gluconeogenesis assay for 
these four plant parts was 10 μg/ml.  
From Figure 3.7 (D), both mangiferin and genkwanin 5-O-β-primeveroside only 
showed significant reduction in cell viability at 1000 μM (62%, P<0.01) and 100 
μM (46%, p<0.01) respectively. Safe concentration ranges for mangiferin and 
genkwanin 5-O-β-primeveroside were determined at 100 μM or below and 10 
μM or below, respectively. For comparability purpose, the concentration ranges 
used in gluconeogenesis assay for mangiferin and genkwanin 5-O-β-
primeveroside were 0.1 to 100 μM and 0.1 to 10 μM, respectively. 
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3.4.2 Gluconeogenesis assay 
Gluconeogenesis assays were performed to investigate the glucose production-
suppression effect of the plant extracts and tea products. For the water extract of 
tea products and plant parts, two separate attempts were performed using batch 
1 and batch 2 test samples, respectively (refer Table 3.6). The average results 
from these two attempts were illustrated in Figure 3.8 (C). Figures 3.8 (A), 3.8 (B) 
and 3.8 (C) show the average glucose concentrations for all test samples based on 
the gluconeogenesis assays. Each assay was performed three times in triplicate. 
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Figure 3.8 – Gluconeogenesis assays for: (A) Non-water extracts of gaharu leaf, 
mangiferin, positive (insulin and metformin) and negative (dexamethasone) drug 
controls, as well as vehicle control (1% DMSO); (B) Genkwanin 5-O-β-
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primeveroside, the negative and positive drug controls, and vehicle control (1% 
MeOH); (C) Water extracts of plant parts and tea products. Data are expressed as 
mean ± SEM (n=3 for A and B; n=6 for C). *; p<0.05, **; p<0.01 and ***; p<0.001. 
Control was well not treated with an extract. 
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3.4.3 Bradford Protein assay 
Bradford protein assay was performed to determine the total amount of cells in each well that were responsible for glucose production in the 
respective gluconeogenesis assay. The glucose concentration of each well was divided by the total amount of cells (measured in μg amount of 
protein) in that particular well to give a normalised glucose concentration. Table 3.8 – 3.10 shows the total amount of protein (μg) determined 
for all the gluconeogenesis assays that were carried out. 
 
Table 3.8 – Total amount of protein determined for the gluconeogenesis assay for acetone extract, methanol extract, mangiferin, insulin, 
metformin, dexamethasone, vehicle control, and control. 
Treatments 
Total amount of protein (μg) 
1st experiment 2nd experiment 3rd experiment 
Acetone extract 
(100 μg/mL) 
729.79 673.54 554.79 786.04 548.54 546.54 614.17 645.42 551.67 
MeOH extract 
(100 μg/mL) 
857.92 929.79 786.04 920.42 764.17 895.42 757.92 873.54 823.54 
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Mangiferin (100 
μM) 
417.29 657.92 429.79 454.79 657.92 429.79 661.04 642.29 448.54 
Mangiferin (10 
μM) 
761.04 289.17 514.17 401.67 273.54 579.79 473.54 804.79 664.17 
Mangiferin (1 
μM) 
1092.29 470.42 329.79 779.79 442.29 436.04 448.54 551.67 398.54 
Mangiferin (0.1 
μM) 
1161.04 679.79 767.29 751.67 942.29 851.67 786.04 726.67 645.42 
Insulin (1 μM) 723.54 923.54 867.29 720.42 873.54 636.04 811.04 823.54 598.54 
Metformin (1 
μM) 
626.67 776.67 570.42 667.29 751.67 748.54 728.54 632.92 757.92 
Dexamethasone 
(1 μM) 
1023.54 398.54 542.29 598.54 470.42 804.79 511.04 482.92 548.54 
Vehicle Control 
(1% DMSO) 
568.20 445.64 462.20 583.52 570.27 607.33 515.20 458.89 561.58 
Control 726.67 486.04 436.04 536.04 420.42 432.91 739.17 529.79 667.29 
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Table 3.9 – Total amount of protein determined for the gluconeogenesis assay for genkwanin 5-O-β-primeveroside, insulin, metformin, 
dexamethasone, vehicle control, and control. 
Treatments 
Total amount of protein (μg) 
1st experiment 2nd experiment 3rd experiment 
Genkwanin 5-O-
β-
primeveroside 
(10 μM) 
723.54 589.17 639.17 667.29  442.29  642.29 551.67 542.29  548.54  
Genkwanin 5-O-
β-
primeveroside 
(1 μM) 
729.79 667.29  567.29  679.79  729.79  661.04 570.42 607.92 629.79  
Genkwanin 5-O-
β-
primeveroside 
(0.1 μM) 
664.17 701.67 623.54  645.42 623.54  539.17 554.79  426.67 567.29  
Insulin (1 μM) 845.42 748.54  626.67 676.67 657.92 567.29 607.92 536.04  642.29  
Metformin (1 
μM) 
526.67 776.67 570.42 467.29  751.67 548.54 548.54  432.92 557.92 
Dexamethasone 
(1 μM) 
1023.54 398.54  542.29  598.54  470.42 804.79 511.04  482.92 548.54  
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Vehicle Control 
(1% MeOH) 
720.42 717.29  695.42 707.92 557.92 807.92 514.17 632.92 595.42 
Control 723.54  532.92 736.04 482.92 729.79  682.92 586.04  429.79  567.29  
 
Table 3.10 – Total amount of protein determined for the gluconeogenesis assay for bark, leaf, twig, young shoot, Gaharu Tea, Gaharu Cool Tea, 
GOGA Drink Powder, and control. 
Treatments 
Total amount of protein (μg) 
1st experiment 2nd experiment 3rd experiment 
Attempt 1 
Bark (10 
μg/ml) 
723.54  714.17 954.79  761.04  904.79  757.92 936.04  923.54  920.42 
Leaf (10 
μg/ml) 
914.17 829.79  970.42 786.04  882.92 932.92 898.54  776.67 892.29  
Twig (10 
μg/ml) 
804.79  689.17 882.92 945.42 861.04  798.54 1311.04  951.67 654.79  
Young Shoot 
(10 μg/ml) 
961.04  879.79  882.92 904.79  879.79  1139.17 754.79  773.54  892.29  
Gaharu Tea 
(10 μg/ml) 
901.67 1242.29  973.54  773.54  1029.79  423.54 992.29  732.92 673.54  
Gaharu Cool 
Tea (10 
664.17 461.04  1348.54  1698.54 842.29  1420.42 1279.79  242.29  998.54  
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μg/ml) 
GOGA Drink 
Powder (10 
μg/ml) 
801.67 729.79  823.54  767.29  911.04  861.04 867.29  689.17 1048.54 
Control 1011.04 1004.79  901.67 654.79  961.04  1120.42 686.04  879.79  748.54 
Attempt 2 
Bark (10 
μg/ml) 
745.42 736.04  976.67 782.92 926.67 779.79 957.92 945.42 1045.42 
Leaf (10 
μg/ml) 
936.04  851.67 992.29  807.92 904.79  954.79 920.42 798.54  914.17 
Twig (10 
μg/ml) 
826.67 711.04  904.79  967.29  882.92 820.42 1332.92 973.54  676.67 
Young Shoot 
(10 μg/ml) 
982.92 901.67 904.79  926.67 901.67 1161.04 776.67 795.42 914.17 
Gaharu Tea 
(10 μg/ml) 
923.54  1264.17 995.42 795.42 1051.67 445.42 1014.17 754.79  695.42 
Gaharu Cool 
Tea (10 
μg/ml) 
686.04  482.92 1139.17 1198.54  239.17 889.17 1301.67 436.04  1020.42 
GOGA Drink 
Powder (10 
μg/ml) 
823.54  1064.17 845.42 789.17 932.92 882.92 889.17 1179.79  1132.92 
Control 1032.92 1339.17 923.54  676.67 982.92 1142.29 707.92 901.67 770.42 
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3.4.4 Normalised gluconeogenesis assay 
The normalised glucose concentration was calculated by dividing the glucose 
concentration (μM) determined for each well with the total amount of protein 
(μg) of the same well as illustrated in Tables 3.8 – 3.10. The normalised data is 
a more accurate representation of glucose production activity as it is 
presented as amount of glucose produced (μM) per amount of protein (μg), 
which eliminate misinterpretation arose from different cell concentration in 
each well. Figures 3.9 (A), 3.9 (B) and 3.9 (C) show the average normalised 
glucose concentrations based on the gluconeogenesis assay results. 
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Figure 3.9 – Normalised gluconeogenesis assays for: (A) Non-water extracts of 
gaharu leaf, mangiferin, positive (insulin and metformin) and negative 
(dexamethasone) drug controls, as well as vehicle control (1% DMSO); (B) 
Genkwanin 5-O-β-primeveroside, the positive and negative drug controls, and 
vehicle control (1% MeOH); (C) Water extracts of plant parts and tea products. 
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Data are expressed as mean ± SEM (n=3 for A and B; n=6 for C). *; p<0.05, **; 
p<0.01 and ***; p<0.001. Control was well not treated with an extract. 
 
From Figure 3.9 (A), cells treated with 100 µg/ml of acetone and MeOH 
extract showed significant glucose production-suppression effect relative to 
control. As for mangiferin, its concentrations used (0.1 µM to 100 µM) 
corresponded well to its glucose-suppression effect, i.e., the highest 
concentration at 100 µM corresponded to the lowest amount of glucose 
detected, while the lowest concentration at 0.1 µM corresponded to the 
highest amount of glucose detected. 1 µM of insulin also showed significant 
glucose suppression activity. As for metformin and dexamethasone, no 
significant difference in glucose production compared to control were 
measured. The vehicle control (1% DMSO) also showed no significant 
difference in glucose production compared to control.  
From Figure 3.9 (B), 10, 1 and 0.1 µM of genkwanin 5-O-β-primeveroside 
showed no significant difference in glucose production relative to control. 1 
µM of insulin, metformin and dexamethasone also showed no significant 
glucose suppression activity. The vehicle control (1% MeOH) also showed no 
significant difference in glucose production compared to control.  
Figure 3.9 (C) showed the average normalised glucose concentration of 
Attempts 1 and 2 gluconeogenesis assay results for the water extracts of tea 
products and plant parts. Both leaf and twig showed significant glucose 
production-suppression effect compared to control, while both bark and 
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young shoot showed no significant glucose suppression activity. Among the 
tea products, both Gaharu Tea and Gaharu Cool Tea showed comparable 
normalised glucose concentration values (0.00172 and 0.00183 M/g, 
respectively), while GOGA Drink Powder showed a much higher value 
(0.00221 M/g). Generally, it appears that the order of glucose suppression 
activity from highest to lowest is Gaharu Tea > Gaharu Cool Tea > GOGA Drink 
Powder.  
The normalised gluconeogenesis assay results for all test samples showed 
identical trend to the results before normalisation (Figure 3.8 versus Figure 
3.9). 
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Chapter Four 
Discussion 
4.1 Isolation and structure determination 
In the present study, four compounds were obtained from 1 kg of dried 
ground leaves of A. sinensis provided by GTSB, which was first exhaustively 
extracted with acetone followed by methanol, giving 70.27 g of crude acetone 
extract and 129.95 g of methanol extract.  
As mentioned in chapter 2.6, mangiferin (1) was obtained from the crude 
acetone extract using the precipitation method with CHCl3:MeOH (1:1) as the 
precipitating solvent. Subsequent recrystallization of the precipitate in 
methanol gave pure mangiferin (1). Following the successful isolation of 
mangiferin (1) based on the TLC profile that showed no other visible 
impurities, 1H NMR and LC-Orbitrap-MS data were acquired for the sample. 
Visual inspection of the 1H NMR spectrum of 1 (see Figure 3.1 and Table 3.2) 
showed characteristic peaks that correlated to those reported for mangiferin 
(Hara, 2008). The LC-Orbitrap-MS data further supported the identity of 1 to 
be mangiferin, which showed a pseudomolecular ion peak at m/z 421.076 
(C19H18O11  H+). 
Our initial focus was to locate flavonoid containing fractions, which showed 
yellowish-green spots when sprayed with ethanolic AlCl3 and viewed under 
UV at 365 nm (longwave). This characteristic was observed in F10 (see Figure 
2.1) of the crude acetone extract filtrate that has been subjected to VCC. After 
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repeated fractionation of F10 using CTLC, compounds 2 and 3 were obtained 
and their 1H NMR and LC-Orbitrap-MS data were acquired. Visual inspection 
of the 1H NMR spectra (see Figure 3.3 and Table 3.3 for compound 2; Figure 
3.4 and Table 3.4 for compound 3) showed characteristic peaks that 
correlated to those of naringenin (Álvarez-Álvarez et al., 2015) and 
iriflophenone 2-O-α-rhamnoside (Hara et al., 2008), respectively. The 
identities of compounds 2 and 3 were further confirmed by the LC-Orbitrap-
MS data. 
Compound 4 (genkwanin 5-O-β-primeveroside), which is quite polar, was 
isolated from the crude MeOH extract instead of the crude acetone extract. 
Similar to other compounds, it was isolated after subsequent VCC and CTLC. 
However, repeated CTLC failed to fully purify compound 4 due to its polar 
nature. Compound 4 was eventually purified using a semi-preparative reverse 
phase HPLC. The 1H NMR spectrum was then acquired for the purified sample. 
Unfortunately, the LC-Orbitrap-MS data is unavailable for 4 as the instrument 
was out of service. Visual inspection of the 1H NMR spectrum of 4 (see Figure 
3.5 and Table 3.5) showed characteristic peaks that correlated to those of 
genkwanin 5-O-β-primeveroside as reported in the literature (Hara et al., 
2008). 
 
4.2 Biological assays 
Gluconeogenesis is the production of glucose from pyruvate and other non-
carbohydrate precursors such as amino acid, glycerol, and lactate (Rang et al., 
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2003). Gluconeogenesis mainly takes place in the liver when the blood glucose 
level is low. In this research, gluconeogenesis assay was employed on human 
liver cell HepG2 to simulate and measure hepatic glucose production in vitro. 
Besides mangiferin and genkwanin 5-O-β-primeveroside, different plant parts 
and tea products extracts were tested to investigate their effect on glucose 
production level of HepG2 cells in the gluconeogenesis assay. There were four 
individual plant parts from the A. sinensis tree, namely, bark, leaf, twig, and 
young shoot. As for the tea products, raw materials of these three products 
were used, namely, Gaharu Tea, Gaharu Cool Tea, and GOGA Drink Powder. 
Gaharu Tea and Gaharu Cool Tea are made up of raw plant parts, whereas 
GOGA Drink Powder is made by spray drying the water extracts of plant parts 
on the maltodextrin filler. These raw materials of the tea products are made 
up of different ratio of ground plant parts, which are summarised in Table 4.1. 
Table 4.1 – Tea products composition. 
Tea 
Products 
Composition (%) 
Bark Leaf Twig 
Young 
Shoot 
Additives 
Gaharu Tea 30.00 20.00 50.00 - - 
Gaharu 
Cool Tea 
27.00 18.00 45.00 10.00 - 
GOGA 
Drink 
Powder 
26.25 17.81 44.06 5.63 
Mogroside V 
(6.25) 
Maltodextrin 
(1:1 Filler) 
 
Multiple studies have shown that mangiferin possessed an array of 
antidiabetic properties such as α-glucosidase inhibition (Feng et al., 2011), 
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and modulation of GLUT4 expression in the plasma membrane of muscle 
(Miura et al., 2001). In a study done by Wang et al. (2016) which was similar to 
this research has shown that mangiferin suppressed gluconeogenesis assay on 
HepG2 human liver cells. According to Figure 3.9 (A), increasing concentration 
of mangiferin from 0.1 μM to 100 μM leads to significant reduction in 
normalised glucose concentration in HepG2 cells. Therefore, it can be 
deduced that higher amounts of mangiferin corresponded to better glucose 
suppression activity. As for genkwanin 5-O-β-primeveroside, there is no 
correlation between the concentration of this compound and the glucose 
suppression activity (see Figure 3.9 (B)). The relationship between glucose 
suppression activity and the amount of mangiferin detected in each of the 
water extracts of the plant parts and tea products is presented in Figure 4.1. 
 
Figure 4.1 – Normalised gluconeogenesis concentrations and mangiferin 
contents associated with the water extracts of different plant parts and tea 
products (see Figure 3.9 (C) and Table 3.7). 
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The leaf water extract exhibited the highest glucose suppression effect, in 
agreement with the highest amount of mangiferin detected within the extract 
(6.00% w/w). Mangiferin was undetectable in the bark and young shoot water 
extracts (presumably due to very low amounts of mangiferin present), which 
explained the lack of glucose suppression activity observed. Twig water 
extract was determined to contain a lower amount of mangiferin (0.50% w/w) 
compared to that of the leaf. This is consistent with the lower glucose 
suppression activity observed for the twig water extract, but was more active 
compared to both the bark and young shoot water extracts.  
The amounts of mangiferin present in the water extracts of Gaharu Tea (1.33% 
w/w) and Gaharu Cool Tea (1.66% w/w) were found to be comparable. This is 
also consistent with the glucose suppression activity observed for the extracts 
of both the tea products. Based on the tea product composition data (Table 
4.1), Gaharu Tea was made up of 20% leaf, 50% twig and 30% bark, while 
Gaharu Cool Tea was made up of 18% leaf, 45% twig, 27% bark and 10% 
young shoot. Since it was observed that only the leaf and twig parts possess 
appreciable amounts of mangiferin, therefore the varying compositions of the 
bark and young shoot parts present in Gaharu Tea and Gaharu Cool Tea have 
little effect on their glucose suppression activity. On the other hand, the low 
amount of mangiferin detected in the water extract of GOGA Drink Powder 
(0.18% w/w) corroborated the low glucose suppression activity exhibited by 
this tea product, of which the activity was almost comparable to that of 
control (which was not treated with an extract).  
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According to Table 3.6, the extraction yields (after filtration) of the water 
extracts of Gaharu Tea and Gaharu Cool Tea are comparable (13.71% and 
15.26%, respectively). As for GOGA Drink Powder, the yield is much higher, 
around 79.88%. This values are analogous to the dissolved content that sipped 
through the tea bag when brewing the tea. For the commercial products, one 
tea bag of Gaharu Tea and Gaharu Cool Tea contains an average of 2.25 g of 
mixed ground plant parts per tea bag. As for GOGA Drink, which is sold as a 
bottled drink (300 ml), each bottle contains an average of 250 mg of water 
extract (obtained from a mixed plant parts) in addition to some additives. The 
amount of mangiferin ingested per serving (one tea bag or one bottle) of each 
of these tea products is illustrated in Table 4.2. 
Table 4.2 – Mangiferin content per serving of Gaharu Tea, Gaharu Cool Tea, 
and GOGA Drink. 
 Gaharu Tea Gaharu Cool 
Tea 
GOGA Drink 
Averaged weight of tea 
material per servinga 
2.25 g 2.25 g 250 mg per 300 
ml 
Averaged TDS yield of 
water extract (%)b 
13.71 15.26 79.88 
Averaged mangiferin 
content (%)c in water 
extract 
1.33 1.66 0.18 
Averaged mangiferin 
content per serving (mg) 
4.10 5.70 0.36 
a These data were provided by GTSB 
b 1% = 1 g of TDS per 100 g of tea material 
c 1% = 1 g of mangiferin per 100 g of TDS 
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As shown in Table 4.2, Gaharu Tea and Gaharu Cool Tea have comparable 
amount of mangiferin per serving, while for GOGA Drink, a much smaller 
amount of mangiferin is present per serving. Therefore, it is speculated that 
consuming Gaharu Tea and Gaharu Cool Tea would result in better glucose 
suppression activity compared to GOGA Drink per serving.  
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Chapter Five 
Conclusion, Research Limitations and Future Works 
5.1 Conclusion 
1.022 g of mangiferin has been successfully isolated and purified from the 
acetone extract (70.27 g) of the leaf material (1 kg), while 0.018 g of 
genkwanin 5-O-β-primeveroside was isolated and purified from the MeOH 
extract (129.95 g) of the same leaf material. Besides the two major 
compounds of interest, 0.021 g of naringenin and 0.03 g of iriflophenone 2-O-
α-rhamnoside have also been isolated from the acetone extract. 
 
The amounts of mangiferin in each plant part and tea product were 
determined by HPLC quantitative analysis, i.e., Twig 0.50%, Leaf 6.00%, 
Gaharu Tea 1.33%, Gaharu Cool Tea 1.66%, and GOGA Drink Powder 0.18%. 
Mangiferin was undetectable in bark and young shoot. Similarly, the amounts 
of genkwanin 5-O-β-primeveroside were determined, i.e., Leaf 0.55%, Gaharu 
Tea 0.15%, and Gaharu Cool Tea 0.11%. Genkwanin 5-O-β-primeveroside was 
undetectable in twig, bark, young shoot, and GOGA Drink Powder. The 
acetone and MeOH extracts were also sent for mangiferin content analysis, 
but not for genkwanin 5-O-β-primeveroside. 5.45% of mangiferin was found in 
the acetone extract, while 9.76% was found in the MeOH extract. 
 
 
 
103 
 
Through MTT assay, safe concentration ranges for all the test samples to be 
used for gluconeogenesis assay were determined. All gluconeogenesis assay 
results were normalised with the total amount of protein from the same well 
plate that was used for gluconeogenesis assay. The normalized data is a more 
accurate representation of glucose production activity as it eliminates 
misinterpretation arose from different cell concentration.  
 
Mangiferin in various concentrations showed significant glucose suppression 
effect, while genkwanin 5-O-β-primeveroside was practically ineffective. The 
acetone and MeOH extracts, which were shown to contain high amounts of 
mangiferin, showed high glucose suppression effect. The leaf water extract, 
which has higher amount of mangiferin detected compared to the twig 
extract, corresponded to a better glucose suppression effect compared to the 
twig extract. Mangiferin was undetectable in bark and young shoot water 
extracts, which corresponded to the high glucose concentration produced. 
Among the tea products, Gaharu Tea and Gaharu Cool Tea have the highest 
amounts of leaf and twig components (consequently, corresponded to higher 
amounts of mangiferin present) and this is consistent with higher glucose 
suppression activity observed. The amount of mangiferin in GOGA Drink 
Powder was low, which is consistent with its very low glucose suppression 
activity. 
 
The averaged mangiferin content per serving (mg) for each of the three tea 
products were also determined, i.e., Gaharu Tea 4.10 mg, Gaharu Cool Tea 
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5.70 mg, and GOGA Drink 0.36 mg. When viewed from the commercialised 
tea products perspective, each sachet of Gaharu Tea and Gaharu Cool Tea has 
comparable amount of mangiferin per serving, whereas a bottle of GOGA 
Drink (300 ml) has lesser amount of mangiferin per serving. 
 
In conclusion, both mangiferin and genkwanin 5-O--primeveroside have 
been isolated in the present study. It has been shown that mangiferin, but not 
genkwanin 5-O--primeveroside, represents the active component that is 
responsible for the glucose suppression activity observed for the tea products. 
 
5.2 Research Limitations and Future Works 
Although this research has successfully yielded four known compounds, two 
of which are the compounds of interest, namely, mangiferin and genkwanin 5-
O--primeveroside, several limitations encountered throughout the research 
period are listed below: 
1. Due to limited resources and time constraint, the bioassays (MTT, 
gluconeogenesis, and Bradford Protein assays) carried out for the 
water extracts of the plant parts and tea products provided 
preliminary results, which require further studies to confirm their 
antidiabetic effects. For future work, RT-PCR to study gene expression 
associated with gluconeogenesis assay should be carried out to 
investigate the effect of mangiferin and the water extracts on gene 
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expression of PEPCK and G6Pase, which are believed to be 
downregulated in the presence of mangiferin (Zhang et al., 2009).   
 
2. Concentration-response curve was not done for the water extracts of 
the plant parts and tea products to determine the optimal 
concentration that will exhibit the best glucose suppression activity. 
Instead, the concentration of 10 µg/mL, which lies within the safe 
region of cell viability, was used for all the water extracts in this 
research. For future work, concentration-response curves should be 
established for all the water extracts of plant parts and tea products. 
 
3. No bioassay was done on naringenin and iriflophenone 2-O-α-
rhamnoside as they were isolated in minute quantity. Previous 
research has shown that iriflophenone 2-O-α-rhamnoside exhibited α-
glucoside inhibitory activity (Feng, 2011). For future work, more 
naringenin and iriflophenone 2-O-α-rhamnoside should be isolated to 
assess their antidiabetic effect. 
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APPENDICES 
Appendix 1 – Aquilaria sienensis. A. Flowering twig. B. Inflorescence. C. Flower 
with part of calyx removed. D. Stigma.E. Petaloid appendages. F. Stamens (in 
front) with petaloid appendages (behind).    
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Appendix 2 – Aquilaria sienensis. A. Fruiting bunch. B. Dehisced fruits with 
seeds hanging on long threadlike funicle. C. Longitudinal section of fruit. D. 
Seed. F. Hairs on seed surface.    
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Appendix 3 – Aquilaria sinensis. Stages of development from flower bud to 
mature fruit. 
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Appendix 4 – HPLC analysis of mangiferin (1) tested against standard 
mangiferin. 
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Appendix 5 – HPLC quantitative analysis of mangiferin in the water extracts of 
plant parts and tea products (by FRIM). 
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Appendix 6 – HPLC quantitative analysis of genkwanin 5-O-β-primeveroside in 
the water extracts of plant parts and tea products (by Permulab Sdn Bhd). 
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Appendix 7 – LC-Orbitrap-MS (negative mode) of mangiferin (1). 
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Appendix 8 – LC-Orbitrap-MS (negative mode) naringenin (2). 
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Appendix 9 – LC-Orbitrap-MS (negative mode) iriflophenone 2-O-α-
rhamnoside (3). 
 
 
